US20130178908A1 - Electrophysiological endocardiology tool - Google Patents

Electrophysiological endocardiology tool Download PDF

Info

Publication number
US20130178908A1
US20130178908A1 US13/737,151 US201313737151A US2013178908A1 US 20130178908 A1 US20130178908 A1 US 20130178908A1 US 201313737151 A US201313737151 A US 201313737151A US 2013178908 A1 US2013178908 A1 US 2013178908A1
Authority
US
United States
Prior art keywords
heart
electrically conductive
instrument
heart wall
elongated member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/737,151
Inventor
Christoph Hans Huber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ENDOHEART AG
Original Assignee
ENDOHEART AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ENDOHEART AG filed Critical ENDOHEART AG
Priority to US13/737,151 priority Critical patent/US20130178908A1/en
Assigned to ENDOHEART AG reassignment ENDOHEART AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HUBER, CHRISTOPH HANS
Publication of US20130178908A1 publication Critical patent/US20130178908A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/3621Heart stimulators for treating or preventing abnormally high heart rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0587Epicardial electrode systems; Endocardial electrodes piercing the pericardium
    • A61N1/0592Introducing the lead through the pericardium with a needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12122Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12136Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491Surgical glue applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00137Details of operation mode
    • A61B2017/00154Details of operation mode pulsed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00606Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00681Aspects not otherwise provided for
    • A61B2017/00694Aspects not otherwise provided for with means correcting for movement of or for synchronisation with the body
    • A61B2017/00703Aspects not otherwise provided for with means correcting for movement of or for synchronisation with the body correcting for movement of heart, e.g. ECG-triggered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00902Material properties transparent or translucent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00929Material properties isolating electrical current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0417T-fasteners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3417Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • A61B17/3421Cannulas
    • A61B17/3423Access ports, e.g. toroid shape introducers for instruments or hands
    • A61B2017/3425Access ports, e.g. toroid shape introducers for instruments or hands for internal organs, e.g. heart ports
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00357Endocardium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/361Image-producing devices, e.g. surgical cameras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/061Blood vessels provided with means for allowing access to secondary lumens
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04CROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
    • F04C2270/00Control; Monitoring or safety arrangements
    • F04C2270/04Force
    • F04C2270/041Controlled or regulated

Definitions

  • Rapid pacing of the heart is often used during therapeutic activities in the heart.
  • the rapid pacing may reduce blood pressure and flow in the heart. This may reduce stress on heart anatomy when therapeutic instruments or prostheses are present in the heart and may interfere with normal blood flow through the heart. For example, when instruments or prostheses are “upstream” from a valve and partially or wholly obstruct flow through the valve, destructive stress can be transmitted to the valve and adjacent tissue.
  • Rapid pacing of the heart often requires applying current from at least two electrodes. Often, a first electrode is placed in contact with the heart and a second electrode is place in contact with the patient's skin. Open surgery provides easy access to heart tissue for deployment of an electrode. Smaller access incisions that are used in percutaneous procedures, however, reduce access to the heart tissue and make it more difficult to apply an electrode to the heart surface or to retain the electrode on the heart surface during the procedure.
  • the heart surface electrode may be replaced by a temporary venous pacing lead that is deployed in a chamber of the heart, for example, a right atrium or a right ventricle.
  • the pacing lead may be deployed via a neck, arm or leg vein.
  • Temporary venous pacing may require intervention that is not required by placement of the heart surface electrode.
  • FIG. 1 shows apparatus in accordance with the principles of the invention along with illustrative anatomy, in cross-section, in connection with which the invention may be practiced;
  • FIG. 2 is a cross-sectional view, oriented like that along lines 2 - 2 (shown in FIG. 1 ), of other apparatus in accordance with the principles of the invention along with anatomy.
  • FIG. 3 shows other apparatus in accordance with the principles of the invention along with anatomy
  • FIG. 4 shows the apparatus and anatomy of FIG. 3 when the apparatus is in a position different from that shown in FIG. 3 ;
  • FIG. 5 shows the apparatus and anatomy of FIG. 3 when the apparatus is in a different position and a different configuration from the position and configuration shown in FIG. 3 ;
  • FIG. 6 shows still other apparatus in accordance with the principles of the invention along with anatomy
  • FIG. 7 shows the apparatus of FIG. 6 when the apparatus in a different position from the position shown in FIG. 6 ;
  • FIG. 8 shows yet other apparatus in accordance with the principles of the invention along with anatomy
  • FIG. 9 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy.
  • FIG. 10 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy
  • FIG. 11 shows the apparatus of FIG. 8 along with yet other apparatus in accordance with the principles of the invention, and yet other apparatus, and anatomy;
  • FIG. 12 shows, in partial cross-section, oriented like that along lines 12 - 12 (shown in FIG. 1 ), of other apparatus in accordance with the principles of the invention
  • FIG. 13 shows a cross-section taken along lines 13 - 13 (shown in FIG. 12 ) of the apparatus shown in FIG. 12 ;
  • FIG. 14 shows a cross-section, oriented like that along lines 13 - 13 (shown in FIG. 12 ), of other apparatus in accordance with the principles of the invention
  • FIG. 15 shows, in partial cross-section, oriented like that along lines 15 - 15 (shown in FIG. 1 ), of other apparatus in accordance with the principles of the invention
  • FIG. 16 shows a cross-section taken along lines 16 - 16 (shown in FIG. 15 ) of the apparatus shown in FIG. 15 ;
  • FIG. 17 shows yet other apparatus in accordance with the principles of the invention along with anatomy
  • FIG. 18 shows a portion, indicated in FIG. 17 as “18,” of the apparatus shown in FIG. 17 ;
  • FIG. 19 shows, in partial cross-section, yet other apparatus in accordance with the principles of the invention along with anatomy
  • FIG. 20 shows a portion, indicated in FIG. 20 as “19,” of the apparatus shown in FIG. 19 ;
  • FIG. 21 shows yet other apparatus in accordance with the principles of the invention along with anatomy
  • FIG. 22 shows a cross-section taken along lines 22 - 22 (shown in FIG. 21 ) of the apparatus shown in FIG. 21 along with anatomy;
  • FIG. 23 shows yet other apparatus in accordance with the principles of the invention along with anatomy
  • FIG. 24 shows a cross-section taken along lines 24 - 24 (shown in FIG. 23 ) of the apparatus shown in FIG. 23 along with anatomy;
  • FIG. 25 shows a cross-section taken along lines 25 - 25 (shown in FIG. 24 ) of the apparatus shown in FIG. 23 along with anatomy;
  • FIG. 26 shows, in partial cross-section, yet other apparatus in accordance with the principles of the invention, that corresponds to a portion of the apparatus shown in FIG. 23 and indicated in FIG. 24 as “ 26 ;”
  • FIG. 27 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy
  • FIG. 28 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy
  • FIG. 29 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy
  • FIG. 30 shows yet other apparatus that may be used in accordance with the principles of the invention.
  • FIG. 31 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy
  • FIG. 32 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy
  • FIG. 33 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy
  • FIG. 34 shows yet other apparatus that may be used in accordance with the principles of the invention.
  • FIG. 35 shows yet other apparatus that may be used in accordance with the principles of the invention.
  • FIG. 36 shows, in partial cross-section, yet other apparatus in accordance with the principles of the invention.
  • FIG. 37 shows a cross-section taken along lines 37 - 37 (shown in FIG. 36 ) of the apparatus shown in FIG. 36 ;
  • FIG. 38 shows a cross-section, oriented like that along lines 37 - 37 (shown in FIG. 36 ), of other apparatus in accordance with the principles of the invention.
  • the apparatus may include an elongated member.
  • the elongated member may include a delivery lumen that is configured to traverse the heart wall.
  • the lumen may have a proximal opening for receiving the instrument and a distal opening for deploying the instrument.
  • the apparatus may include an outer surface that is configured to maintain the access opening.
  • the apparatus may include an electrically conductive member.
  • the electrically conductive member may be supported by the elongated member.
  • the electrically conductive member may be configured to deliver to the heart wall a current that modifies a contraction frequency of the heart.
  • the apparatus may include one, two, three, four, 10 or more, or any suitable number of electrically conductive members.
  • the electrically conductive member may be an electrode.
  • the electrically conductive member may be used to provide current to the heart in conjunction with another electrically conductive member that is placed elsewhere in the heart, on the heart, or on the patient's skin and also provides pacing current to the patient's tissue.
  • the elongated member may include any suitable biocompatible material such as polymer, stainless steel, nickel titanium alloy or any other suitable material.
  • the apparatus may include, for each electrically conductive member, a current supply lead.
  • the current supply lead may receive one or more cardiac pacing signals from a cardiac pacing signal generator.
  • a connector may be provided for placing the current supply lead in electrical communication with the cardiac pacing signal generator.
  • the cardiac pacing signal generator may include any suitable pacing device.
  • more than one of the apparatus may be used together.
  • a first instrument having electrically conductive members for transferring pulses to the heart and a second instrument having electrically conductive members for transferring pulses to the heart may be coaxially arranged, the first inside the second.
  • the first instrument may be extend from the distal end of the second instrument and be advanced into the myocardium to perform a first procedure.
  • pulses may be transferred to the heart from the first instrument.
  • the second instrument may be advance along the first instrument into the myocardium.
  • pulses may be transferred to the heart from the second instrument.
  • a current switch may be provided to transfer electrical energy from the first instrument to the second instrument.
  • the current switch may analyze an electrical characteristic of one or both of the first and second instruments to detect the succession of the second instrument in the access opening.
  • the current switch may deactivate the first instrument and activate the second instrument upon or about the time of the succession.
  • the electrical characteristic may include a continuity.
  • the electrical characteristic may include an impedance.
  • Table 1 lists illustrative instruments that may be delivered using the apparatus.
  • Illustrative instruments that may be delivered using the apparatus.
  • Illustrative instrument Ablation catheter Access closure device Aneurysm sealing device Aortic endostent Catheter Coronary stent Decalcification tool Defibrillator Delivery system Embolic protection device Embolism preventer Endoprosthesis Heart assist device Heart valve Heat sink Heat source Introducer Microwave emitter Needle Occluder device Pacemaker Plug tool Radio frequency radiation emitter Valve Valve reconstruction tool (e.g., clip) Valve removal tool Wire
  • Table 2 lists illustrative procedures that may be carried out using the apparatus.
  • Illustrative procedures that may be carried out using the apparatus.
  • Illustrative procedure Aneurysm repair Cardiac defibrillation Cardiac pacing Coronary dilatation Coronary stenting Decalcification of cardiac structures Endocardiac arrhytH m ia mapping Heart and hemodynamic support Heart valve reconstruction
  • Heart valve repair Hemodynamic diagnostic assessments Hemodynamic recording Removal of hypertrophic obstructions (obstructions distal to a heart valve) Repair dissected blood vessel Repair ruptured blood vessel Replacement of dissected blood vessel Replacement of ruptured blood vessel Resynchronization therapy
  • Stemcell therapy Transcatheter valve implantation
  • Transcatheter valve insertion Transcatheter valve replacement Treatment of subvalvular stenosis (an obstruction proximal to a heart valve) Ventricular arrhytH m ia repair
  • the electrically conductive member may be configured to provide to the heart wall a series of pulses.
  • the pulses may be quantified by pacing parameters.
  • the pacing parameters may include voltage, current, energy, duration, pulse frequency, maxima and minima thereof, and any other suitable pacing parameters.
  • Table 3 shows illustrative ranges of some pacing parameters.
  • Each pulse may carry from about 0.1 to about 40 milliamp (“mA”). Each pulse may have a duration that is in the range of about 0.1 to about 100 millisecond (“ms”). The pulses may be delivered with a frequency of about 10 to about 300 pulses per second.
  • the electrically conductive member may include copper, silver, gold, platinum, polymer or any other suitable conductive material.
  • the electrically conductive member may include conductive wire, tape, foil, sheet, rod, bar, tube, shot or any other suitable form.
  • the electrically conductive member may be configured to be in direct contact with the heart wall.
  • the electrically conductive member may be configured to be in indirect contact with the heart wall.
  • the electronically conductive member may rest upon the outer surface.
  • the electronically conductive member may be partially or wholly recessed into the elongated member.
  • the electronically conductive member may be partially or wholly recessed relative to the outer surface into the elongated member.
  • the outer surface may be configured to slide through the access opening.
  • the distal opening may displace from a first location to a second location.
  • the first location may be in the heart, in a first chamber of the heart or in the vasculature.
  • the second location may be in the heart, in a first chamber of the heart, in a second chamber of the heart or in the vasculature.
  • the first chamber may be an aorta or a ventricle.
  • the second chamber may be an aorta or a ventricle.
  • the vasculature may include an artery.
  • the vasculature may include a vein.
  • the artery may be a pulmonary artery, a carotid artery, a coronary artery or any other suitable artery.
  • the vein may a vena cava, a pulmonary vein, a coronary vein or any other suitable vein.
  • the electrically conductive member may be configured to slide through the access opening while the electrically conductive delivers the current to the heart wall.
  • the electrically conductive member may be configured to be in direct contact with the heart wall while the electrically conductive member slides through the access opening. Contact between the electrically conductive member and the heart wall may be largely independent of positioning of the elongated member in the heart wall.
  • the apparatus may include an antenna that is supported by the elongated member and is configured to sense a native cardiac electric field in a chamber on the interior side of the heart wall.
  • the antenna may communicate a corresponding native cardiac signal to a receiver exterior the heart wall.
  • the receiver may be part of an electrocardiograph device.
  • the antenna may communicate the cardiac signal via a transmission line.
  • the antenna may communicate the cardiac signal wirelessly.
  • the apparatus may include a pressure sensor.
  • the pressure sensor may be supported by the elongated member.
  • the pressure sensor may be supported by the electrically conductive member.
  • the pressure sensor may be configured to sense a pressure in the chamber.
  • the pressure sensor may be configured to sense a pressure in the heart wall.
  • the pressure sensor may be configured to transmit a corresponding pressure signal to a receiver exterior the heart wall.
  • the antenna may communicate the pressure signal via a transmission line.
  • the antenna may communicate the pressure signal wirelessly.
  • the apparatus may include a chemical sensor.
  • the chemical sensor may be supported by the elongated member.
  • the chemical sensor may be supported by the electrically conductive member.
  • the chemical sensor may be configured to measure chemical values such as, for example, pH, lactate, cardiac enzymes, electrolytes.
  • the chemical sensor may be configured to transmit a corresponding signal to a receiver exterior the heart wall.
  • the chemical sensor may transmit the chemical signal via a transmission line.
  • the chemical sensor may transmit the chemical signal wirelessly.
  • the chemical sensor may be calibrated to sense a chemical species.
  • the species may be present in a chamber interior the heart wall.
  • the species may be present at a myocardial tissue surface that is exposed in a heart wall access opening and transmit a corresponding chemical signal to a receiver exterior the heart wall.
  • the chemical sensor may detect the chemical value based on conductivity of the heart wall.
  • the chemical sensor may detect the chemical value based on capacitance of the heart wall.
  • the chemical sensor may detect the chemical value based on an electrical potential of the heart wall.
  • the chemical sensor may include a porous layer.
  • the chemical sensor may detect the chemical value based on conductivity of the porous layer.
  • the chemical sensor may detect the chemical value based on capacitance of the porous layer.
  • the chemical sensor may detect the chemical value based on an electrical potential of the porous layer.
  • the apparatus may include a processor that is configured to change a pacing parameter, for example, a frequency of the current based on the native cardiac signal.
  • the processor may be configured to change the pacing parameter based on one or more pressure signal.
  • the processor may be configured to change the pacing parameter based on one or more chemical signal.
  • the outer surface may apply pressure to the heart wall.
  • the pressure may be sufficient to prevent blood transmission between the outer surface and the heart wall.
  • the outer surface may apply contact pressure to the heart wall.
  • the pressure may substantially prevent blood leakage between the outer surface and the heart wall by resisting pressure from the heart muscle upon the outer surface.
  • the blood transmission may be prevented in the absence of a sealing element, proximate the access opening, on an interior side of the heart wall.
  • the elongated member may be configured to be maintained in a position, relative to the access opening, without an anchor that fixes the elongated member to the heart wall. When the elongated member is maintained in the position, it may be maintained such that it counters pressure of blood inside the heart.
  • the elongated member may include a proximal portion that is configured to be grasped by any suitable stabilization structure.
  • the elongated member may have a longitudinal position, relative to the access opening, that is maintained primarily by the structure.
  • the elongated member may have a longitudinal position, relative to the access opening, that is maintained exclusively by the structure.
  • the structure may be a human hand.
  • the structure may be a robotic manipulator.
  • the electrically conductive member may be configured to be released from the elongated member and inserted in the heart wall.
  • the electrically conductive member may be inserted into the endocardium.
  • the electrically conductive member may be inserted into the myocardium.
  • the electrically conductive member may be inserted into the pericardium.
  • the electrically conductive member may be fixed onto the endocardium.
  • the electrically conductive member may be fixed onto the myocardium.
  • the electrically conductive member may be fixed onto the pericardium.
  • the electrically conductive member may be anchored in the heart wall.
  • the electrically conductive member may be anchored by a barb, a coil or any other suitable anchor.
  • the electrically conductive member may be a wire.
  • the wire may have a distal end that is driven into the heart wall.
  • the electrically conductive member may be configured to be released from the elongated member and placed on the heart wall.
  • the electrically conductive member may be left in place in the heart wall after removal of the elongated member from the access opening.
  • the electrically conductive member may later be removed from the heart.
  • the elongated member may include a deployment lumen that is configured to direct the electrically conductive member into the heart wall.
  • the elongated member may include an annular wall about the delivery lumen.
  • the deployment lumen may run longitudinally within the annular wall.
  • the deployment lumen may terminate at an orifice in the outer surface.
  • the elongated member may not include a deployment lumen.
  • the elongated member when the elongated member is solid, as in a wire or a non-cannulated rod, the elongated member may not include a deployment lumen.
  • the wire may be part of a delivery system for delivering a prosthetic valve into the heart.
  • the prosthetic valve may be crimped onto a distal tip of the wire.
  • the wire, with the valve may be inserted into the access opening.
  • the outer surface of the wire may be in contact with the heart wall.
  • the contact may be direct contact.
  • the wire, with the valve may be inserted through the access opening within a sheath.
  • the sheath may maintain the valve in an unexpanded state until the valve is in position for deployment.
  • the sheath may be withdrawn proximally to allow a distal end of the valve to expand and engage heart anatomy. Further withdrawal of the sheath may allow a proximal end of the valve to expand and engage heart anatomy.
  • the wire, with the valve, may be inserted through an introducer.
  • the introducer may have an outer surface that is in contact with the heart wall.
  • the contact may be direct contact.
  • the apparatus may include one, two, three, four, 10 or more, or any suitable number of deployment lumens.
  • Each of the deployment lumens may correspond to one or more electrically conductive members.
  • the elongated member may include a distal surface that is configured to abut pericardial tissue adjacent the access opening.
  • the deployment lumen may terminate at an orifice in the distal surface.
  • the apparatus may include a control link.
  • the control link may be configured to displace the electrically conductive member along the deployment lumen and into the heart wall.
  • the control link may be configured to detach from the electrically conductive member when the electrically conductive member is lodged in the heart wall.
  • the control link may urge the electrically conductive member by contacting the electrically conductive member at a location on the electrically conductive member that is distal a portion of the electrically conductive member that initially engages the heart wall.
  • the control link may urge the electrically conductive member by contacting the electrically conductive member at a location on the electrically conductive member that is proximal a portion of the electrically conductive member that initially engages the heart wall.
  • the apparatus may include a conductor that is attached to the electrically conductive member and runs proximally from the electrically conductive member through the deployment lumen.
  • the apparatus may include a second deployment lumen.
  • the second deployment lumen may be configured to direct the electrically conductive member into the heart wall.
  • the second deployment lumen may run longitudinally, with respect to the elongated member, within an annular wall about the delivery lumen.
  • the second deployment lumen may terminate at an orifice in the outer surface.
  • the apparatus may include a second electrically conductive member that is supported by the elongated member.
  • the second electrically conductive member may be configured to deliver to the heart wall a current that modifies the contraction frequency.
  • the electrically conductive member may be embedded in the outer surface.
  • the electrically conductive member may be substantially flush with the outer surface.
  • the electrically conductive member may extend away from the outer surface.
  • the electrically conductive member may extend radially, relative to a longitudinal axis of the elongated member, away from the outer surface.
  • the apparatus may include a blood retention diaphragm having an instrument orifice.
  • the instrument orifice may be expandable.
  • the diaphragm may be disposed in the delivery lumen.
  • the diaphragm may be positioned in the access opening.
  • the elongated member includes a needle.
  • the outer surface may have, in a distal region, a distal diameter; and, in a proximal region, a proximal diameter that is greater than the distal diameter.
  • the elongated member may include a catheter.
  • the catheter may have an inside diameter in the range of about 0.1 to about 3 millimeter (“mm”); and an outside diameter in the range of about 1 to about 4 mm.
  • the inside diameter may have any suitable length.
  • the outside diameter may have any suitable length.
  • the catheter may be part of a delivery system for delivering a prosthetic valve into the heart.
  • the prosthetic valve may be crimped onto a distal tip of the catheter.
  • the catheter, with the valve may be inserted into the access opening.
  • the outer surface of the catheter may be in contact with the heart wall.
  • the contact may be direct contact.
  • the catheter, with the valve may be inserted through the access opening within a sheath.
  • the sheath may maintain the valve in an unexpanded state until the valve is in position for deployment.
  • the sheath may be withdrawn proximally to allow a distal end of the valve to expand and engage heart anatomy. Further withdrawal of the sheath may allow a proximal end of the valve to expand and engage heart anatomy.
  • the catheter, with the valve, may be inserted through an introducer.
  • the introducer may have an outer surface that is in contact with the heart wall.
  • the contact may be direct contact.
  • the catheter may be any suitable size, including about 33Fr to about 24Fr and any suitable sizes below, within or above that range.
  • the elongated member may include an introducer.
  • the introducer may have an inside diameter in the range of about 0.1 to about 18 mm; and an outside diameter in the range of about 5 to about 20 mm.
  • the inside diameter may have any suitable length.
  • the outside diameter may have any suitable length.
  • a portion of the elongated member may be in a contracted state.
  • the contracted state may be a mechanical equilibrium state.
  • a corresponding portion of the electrically conductive member may be disposed at a first radial distance from a longitudinal central axis of the delivery lumen.
  • the portion of the elongated member may be changed to an expanded state.
  • the corresponding portion of the electrically conductive member may be disposed at a second radial distance from the axis. The second radial distance may be greater than the first radial distance.
  • the portion of the electronically conductive member may be a first portion of the electronically conductive member.
  • a second portion of the electrically conductive member which may be disposed longitudinally away from the first portion, may be disposed at the first radial distance from the axis.
  • the elongated member may include material that is configured to deform radially in response to displacement through the delivery lumen of an instrument having an outer diameter that is greater than an inner diameter of the lumen.
  • the material may be configured to elastically relax after passage of the instrument. Relaxation of the material may return the first portion of the electrically conductive member substantially to the first radial distance.
  • the material is configured so that the inner diameter remains deformed substantially commensurate with the outer diameter of the instrument after passage of the instrument.
  • the instrument that displaces the elongated member may be a blunt rod.
  • the instrument that displaces the elongated member may be a therapeutic device.
  • the instrument that displaces the elongated member may be a prosthetic heart valve or any other suitable therapeutic device such as one or more of the devices described or shown herein.
  • the apparatus may include a body.
  • the body may include a distal end.
  • the distal end may be configured to be disposed interior the heart.
  • the distal end may be configured to contact endocardial tissue adjacent the access opening.
  • the apparatus may include a proximal end.
  • the proximal end may be configured to be disposed exterior the heart.
  • the proximal end may be configured to contact pericardial tissue adjacent the access opening.
  • the apparatus may include an electrode.
  • the electrode may be supported by the body.
  • the electrode may be configured to discharge electrical energy into the heart wall to change a frequency of contraction of the heart.
  • the apparatus may include any suitable number of electrodes.
  • the plug may include, for each electrode, a current supply lead.
  • the current supply lead may receive one or more cardiac pacing signals from a cardiac pacing signal generator.
  • a connector may be provided for placing the current supply lead in electrical communication with the cardiac pacing signal generator.
  • the cardiac pacing signal generator may include any suitable pacing device.
  • the body may include a stem that extends between the distal end and the proximal end.
  • the body may include a shaft that extends between the distal end and the proximal end.
  • the shaft may have one or more features in common with the stem.
  • the stem may have a first diameter.
  • the distal end may have a second diameter.
  • the second diameter may be greater than the first diameter.
  • the proximal end may have a third diameter.
  • the third diameter may be greater than the first diameter.
  • the electrode may discharge from the distal end.
  • the electrode may discharge from the proximal end.
  • the electrode may discharge from the stem.
  • the electrode may discharge from the shaft.
  • the body may include a second electrode.
  • the second electrode may be configured to discharge electrical energy into the heart wall to change the frequency of contraction of the heart.
  • the body may include a sensor for sensing a native cardiac electric field.
  • the body may include, in the distal end, a sensor for sensing a blood pressure inside the heart.
  • the body may include a sensor for measuring chemical values inside the heart.
  • the sensor may be disposed in the distal end.
  • the sensor may be disposed on the stem.
  • the sensor may be disposed on the shaft.
  • the chemical sensor may be supported by the elongated member.
  • the chemical sensor may be supported by the electrically conductive member.
  • the chemical sensor may be configured to measure chemical values such as, for example, pH, lactate, cardiac enzymes, electrolytes.
  • the chemical sensor may be calibrated to sense a chemical species.
  • the species may be present in a chamber interior the heart wall.
  • the species may be present at a myocardial tissue surface that is exposed in a heart wall access opening.
  • the chemical sensor may detect the chemical value based on conductivity of the heart wall.
  • the chemical sensor may detect the chemical value based on capacitance of the heart wall.
  • the chemical sensor may detect the chemical value based on an electrical potential of the heart wall.
  • the chemical sensor may include a porous layer.
  • the chemical sensor may detect the chemical value based on conductivity of the porous layer.
  • the chemical sensor may detect the chemical value based on capacitance of the porous layer.
  • the chemical sensor may detect the chemical value based on an electrical potential of the porous layer.
  • the sensor may transmit a chemical value signal based on the chemical value to a processor outside the heart.
  • the sensor may transmit the chemical value sensor by wire.
  • the sensor may transmit the chemical value sensor wirelessly.
  • the body may include an electrical energy storage source such as a battery.
  • the body may include a pacing signal generator.
  • the battery may supply electrical current to the electrodes.
  • the signal generator may control the current so that the current is provided in a therapeutic form.
  • the battery may be separate from the body.
  • the battery may be separately implantable in the patient and in wired electrical communication with the body.
  • the battery may be inductively recharged from a source exterior the patient.
  • the apparatus may include a processor that is configured to change a pacing parameter, for example, a frequency of the current based on the native cardiac signal.
  • the processor may be configured to change the pacing parameter based on one or more pressure signal.
  • the processor may be configured to change the pacing parameter based on one or more chemical signal.
  • the methods may include inserting an elongated member through an access opening in the heart.
  • the methods may include transferring electrical energy from the elongated member to the heart to change a frequency of contractions of the heart.
  • the methods may include delivering an instrument through the elongated member.
  • the transferring may include discharging the electrical energy across a contact interface between the elongated member and the heart.
  • the method may include sensing an electric field of the heart at the elongated member.
  • the method may include changing the contraction frequency based on the electric field.
  • the method may include sensing a blood pressure in the heart at the elongated member.
  • the method may include changing the frequency based on the pressure.
  • the method may include sensing a chemical value in the heart at the elongated member.
  • the method may include changing the contraction frequency based on the chemical value.
  • the method may include preventing blood loss through the access opening by maintaining the elongated member in the access opening.
  • the delivering may include delivering a guide wire.
  • the delivering may include delivering a catheter.
  • the delivering may include delivering an introducer.
  • the delivering may include delivering a introducer.
  • the introducer may include a hemostatic valve.
  • the delivering may include delivering an ultrasound receiver.
  • the delivering may include delivering an embolic protection device.
  • the delivering may include delivering a valve resection device.
  • the resection device may be used to resect a heart valve.
  • the resection device may be used to treat a hypertrophic obstruction.
  • the resection device may be used to treat a subvalvular obstruction.
  • the delivering may include delivering a prosthetic valve.
  • the valve may be a stent valve.
  • the stent valve may be self-expanding.
  • the stent valve may be balloon-expandable.
  • the method may include deploying from the elongated member an access opening plug.
  • the method may include transferring electrical energy from the plug to the heart to change the frequency of contractions of the contractions.
  • the method may include displaying a live image of the elongated member as positioned inside the access opening.
  • the method may include displaying, adjacent the live image, a native cardiac electric field trace.
  • the method may include displaying, adjacent the live image, an internal cardiac blood pressure trace.
  • the apparatus may include a sharp end that is configured to pierce tissue; a base opposite the sharp end, the base being configured to receive an impulse to drive the sharp end into the tissue; an elongated member bearing an electrode, the elongated member extending from the sharp end to the base; and an electrically conducting lead that is connected to the electrode and is configured to receive current for delivery to the heart through the electrode when the electrode is embedded in the heart.
  • the electrode may be elongated along a longitudinal direction of the elongated member.
  • the apparatus may include a second electrode that is borne by the elongated member; and a second electrically conducting lead that is connected to the electrode and is configured to receive current for delivery to the heart through the second electrode when the second electrode is embedded in the heart.
  • the base may be configured to receive the impulse from a firing peg, a spring, a pressurized gas, or any other suitable impulse source.
  • the base may include a magnet.
  • the base may be configured to receive the impulse from a magnetic field.
  • the magnetic field may be provided by a coil.
  • Apparatus and methods described herein are illustrative. Apparatus and methods of the invention may involve some or all of the features of the illustrative apparatus and/or some or all of the steps of the illustrative methods. The steps of the methods may be performed in an order other than the order shown and described herein. Some embodiments may omit steps shown and described in connection with the illustrative methods. Some embodiments may include steps that are not shown and described in connection with the illustrative methods.
  • FIG. 1 schematically shows illustrative instrument 100 for performing a procedure on a heart such as heart H.
  • the procedure may be performed on anatomy in or about heart H.
  • the procedure may be performed on anatomy in or about a chamber of heart H such as chamber H c .
  • Chamber H c may be a left ventricle, a right ventricle, a left atrium or a right atrium.
  • the procedure may be performed on vasculature in or about heart H or on any other structure in or about heart H.
  • Heart H may contract at a frequency.
  • Heart H may include pericardium H p , myocardium H m and endocardium H e .
  • Heart H may include apex Ha.
  • Heart H may include heart wall H.
  • Heart wall H w may include one or more of pericardium H p , myocardium H m and endocardium H e .
  • Heart wall H w may include a septum between two cardiac atria.
  • Heart wall H w may include a septum between two cardiac ventricles.
  • Instrument 100 may include elongated member 102 .
  • Elongated member 102 may be cannulated.
  • Elongated member 102 may include outer surface 104 .
  • Outer surface 104 may resist closure of access opening H o in heart wall H.
  • the pressure of heart wall H w on outer surface 104 may be sufficient to prevent the leakage of blood H b from interior H, of chamber H, between outer surface 104 and heart wall H w to exterior H ext of heart H.
  • the pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 104 and heart wall H.
  • Instrument 100 may include one or more electrically conductive members such as representative electrically conductive member 106 .
  • One or more of electrically conductive members 106 may be supported by elongated member 102 .
  • One or more of electrically conductive members 106 may be supported by outer surface 104 .
  • One or more of electrically conductive members 106 may be used to provide electrical pulses to heart wall H w to change the contraction frequency.
  • One or more of electrically conductive members 106 may be placed in direct contact with heart wall H w to provide the electrical pulses.
  • the energy may be supplied via a cable such as 108 from source 110 .
  • the energy may be supplied wirelessly from source 110 .
  • Source 110 may be programmable via control panel 112 .
  • Source 110 may be incorporated into instrument 100 .
  • Source 110 may be or include a pacing device.
  • One or more additional electrically conductive members may have a distal end that is placed in electrical communication with epidermal tissue on the body in which the heart is disposed.
  • the one or more additional electrically conductive members may have a proximal end that is in electrical communication with control panel 112 .
  • Instrument 100 may be displaced along longitudinal axis L. Instrument 100 may be rotated in circumferential direction ⁇ . Instrument 100 may be radially tapered, along axis L, with respect to radial direction R. Instrument 100 may deliver the pulses while instrument 100 is moving longitudinally. Instrument 100 may deliver the pulses while instrument 100 is rotating.
  • One or more of electrically conductive members 106 may remain in direct contact with heart wall H w while instrument 100 is moving longitudinally. One or more of electrically conductive members 106 may remain in direct contact with heart wall H w while instrument 100 is rotating. One or more of electrically conductive members 106 may have a length Le. Access opening H o may have a thickness t o . Length Le may be greater than thickness t o such that instrument 100 may move longitudinally without removing the electrically conductive member from contact with heart wall H.
  • One or more of electrically conductive members 106 may sense a native cardiac electric field.
  • a signal corresponding to the field may be transmitted to source 110 .
  • the signal may be transmitted via cable 108 .
  • the signal may be transmitted wirelessly.
  • Instrument 100 may include one or more electrically conductive members 106 that are wired to provide pulses to heart wall H w and one or more electrically conductive members 106 that are wired to transmit a native cardiac electric field signal to an electrocardiograph device.
  • Instrument 100 may include one or more antennae such as representative antenna 114 .
  • Antennae 114 may sense a native cardiac electric field.
  • a signal corresponding to the field may be transmitted to source 110 .
  • the signal may be transmitted via cable 108 .
  • the signal may be transmitted wirelessly.
  • Instrument 100 may include one or more pressure sensors such as representative pressure sensor 116 .
  • Pressure sensor 116 may sense a pressure of blood H b .
  • a signal corresponding to the pressure may be transmitted to source 110 .
  • the signal may be transmitted via cable 108 .
  • the signal may be transmitted wirelessly.
  • Instrument 100 may include one or more pressure sensors such as representative pressure sensor 119 .
  • Pressure sensor 119 may have one or more features in common with pressure sensor 116 .
  • Pressure sensor 119 may be one of an array of pressure sensors.
  • Pressure sensor 119 may sense the pressure of heart wall H w against outer surface 104 in access opening H o .
  • Each of the pressure sensors in the array may be monitored individually so that a reading may be taken from one or more of the pressure sensors that is in access opening H o .
  • elongated member 102 is in different longitudinal positions relative to heart wall H w , it may be necessary or desirable to monitor the pressure sensed by a sensor that is inside access opening H o and not in chamber H c or in the exterior H ext of the heart. In this way, the pressure in access opening H c can be monitored while elongated member 102 is in different positions or is in motion.
  • Instrument 100 may include one or more chemical sensors such as representative chemical sensor 117 .
  • a signal corresponding to the concentration of a chemical may be transmitted to source 110 .
  • the signal may be transmitted via cable 108 .
  • the signal may be transmitted wirelessly.
  • Instrument 100 may include one or more chemical sensors such as representative chemical sensor 107 .
  • Chemical sensor 107 may have one or more features in common with chemical sensor 117 .
  • Chemical sensor 107 may be one of an array of chemical sensors. Chemical sensor 107 may sense the presence at an exposed surface of heart wall H w in access opening H o of a chemical compound or species. Each of the chemical sensors in the array may be monitored individually so that a reading may be taken from one or more of the chemical sensors that is in access opening H o .
  • elongated member 102 is in different longitudinal positions relative to heart wall H w , it may be necessary or desirable to monitor the chemical value sensed by a sensor that is inside access opening H o and not in chamber H c or in the exterior H ext of the heart. In this way, the chemical value in access opening H c can be monitored while elongated member 102 is in different positions or is in motion.
  • One or more of the pressure sensors and chemical sensors may have a length Ls.
  • Length Ls may be lesser than thickness t o such that when instrument 100 moves longitudinally through heart wall H w , one of the pressure sensors or chemical sensors will sense, respectively, a pressure or chemical signal that is representative of heart wall H w .
  • Ls may be in the range of about t o to t o /2, t o /2 to about t o /4, about t o /4 to t o /8 or smaller.
  • the pulses may be defined by parameters such as energy, duration, frequency, voltage, current and any other suitable parameters.
  • the parameters may be selected manually via control panel 112 .
  • Source 110 may include one or more control algoritH m s for setting one or more parameters of the pulses.
  • the algoritH m s may be selected via control panel 112 .
  • the algoritH m s may include settings that may be adjusted via control panel 112 .
  • Instrument 100 may be used to deploy another instrument such as catheter C, guidewire W or any other instrument.
  • One or more of the elements of instrument 100 may be embodied in a needle, a catheter, an introducer or any other instrument that may be involved in the procedure.
  • Obliterator 101 When instrument 100 is an introducer, it may be used together with obliterator 101 .
  • Obliterator 101 may be a cannulated element that nests coaxially inside instrument 101 .
  • Obliterator 101 may include taper 103 .
  • Taper 103 may be extended distally of instrument 101 to present taper 103 to access hole H o when access hole H o is too small to accept the diameter of instrument 101 .
  • Taper 103 may be used to open access hole H o to accept instrument 101 .
  • Obliterator 101 may then be withdrawn proximally from instrument 100 to enable instrumentation to pass through the inside diameter of instrument 100 .
  • Source 110 may be communication, for example, via cable 118 , or wirelessly, with other clinical signals.
  • source 110 may exchange information with a medical imaging system (not shown).
  • the medical imaging system may provide an image of instrument 100 during the procedure.
  • the image may be a fluoroscopic image or any other suitable image.
  • Source 110 may provide information such as the native cardiac field, the pressure or any other suitable information.
  • the image and the information may be displayed together on display 120 .
  • Display 120 may be collocated with instrument 100 , for example, in the same operating theater.
  • Display 120 may be located remotely from instrument 100 , for example, at a distant location for observation by a distant practitioner.
  • display 120 may display image 122 , electric field trace 124 , pressure trace 126 or any other suitable trace.
  • the image and the traces may be live and may be combined into an integrated image signal before being displayed by display 120 .
  • FIG. 2 shows a view taken along lines 2 - 2 (shown in FIG. 1 ).
  • FIG. 2 shows elongated member 102 in access opening H o .
  • outer surface 104 is in direct contact with myocardium H m .
  • one of electrically conductive members 106 is in direct contact with myocardium H m .
  • one of electrically conductive members 106 is in indirect contact with myocardium H m .
  • fluid F intervenes between the electrically conductive member and myocardium H m .
  • Fluid F may include blood, such as blood H b .
  • Fluid F may include an irrigation fluid, such as water or saline solution. Fluid F may include any other suitable fluid.
  • one of electrically conductive members 106 is in indirect contact with myocardium H m .
  • fluid F and gas G intervene between the electrically conductive member and myocardium H m .
  • Gas G may include air.
  • FIGS. 3-10 show illustrative steps of a procedure that may involve apparatus having features such as those illustrated in connection with instrument 100 (shown in FIG. 1 ).
  • FIG. 3 schematically shows illustrative access needle 300 penetrating heart wall H w of heart H.
  • Needle 300 may include elongated member 302 .
  • Elongated member 302 may include tissue-piercing tip 303 .
  • Elongated member 302 may include outer surface 304 .
  • Outer surface 304 may resist closure of access opening H o in heart wall H.
  • the pressure of heart wall H w on outer surface 304 may be sufficient to prevent the leakage of blood H b from interior H i of chamber H c between outer surface 304 and heart wall H w to exterior H ext of heart H.
  • the pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 304 and heart wall H.
  • Needle 300 may include one or more electrically conductive members such as representative electrically conductive member 306 .
  • One or more of electrically conductive members 306 may be supported by elongated member 302 .
  • One or more of electrically conductive members 306 may be supported by outer surface 304 .
  • One or more of electrically conductive members 306 may be used to provide electrical pulses to heart wall H w to change the contraction frequency.
  • Needle 300 may include an delivery lumen (not shown).
  • the delivery lumen may be used to deliver an instrument to interior H i .
  • the instrument may be any suitable instrument, such as guidewire G.
  • FIG. 4 shows needle 300 advanced longitudinally through heart wall H w . Electrically conductive members 306 remain in contact with heart wall H w .
  • FIG. 5 shows wire W advanced longitudinally through needle 300 .
  • Wire W passes through aortic valve H AV into arterial vasculature (not shown).
  • a distal end (not shown) of wire W may be captured by instrumentation (not shown) in the arterial vasculature.
  • Wire W may be advanced through mitral valve H mv .
  • Electrically conductive members 306 remain in contact with heart wall H w .
  • FIG. 6 schematically shows illustrative catheter 600 in access opening H o .
  • Catheter 600 may have replaced needle 300 (shown in FIG. 3 ). Wire W may have been left in place upon the removal of needle 300 .
  • Catheter 600 may have been guided into chamber H c along wire W.
  • Catheter 600 may include elongated member 602 .
  • Elongated member 602 may include outer surface 604 .
  • Outer surface 604 may resist closure of access opening H o in heart wall H w .
  • the pressure of heart wall H w on outer surface 604 may be sufficient to prevent the leakage of blood H b from interior H i of chamber H c between outer surface 604 and heart wall H w to exterior H ext of heart H. The pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 604 and heart wall H w .
  • Catheter 600 may include one or more electrically conductive members such as representative electrically conductive member 606 .
  • One or more of electrically conductive members 606 may be supported by elongated member 602 .
  • One or more of electrically conductive members 606 may be supported by outer surface 604 .
  • One or more of electrically conductive members 606 may be used to provide electrical pulses to heart wall H w to change the contraction frequency.
  • FIG. 7 shows wire catheter 600 (shown in FIG. 6 ) advanced longitudinally through access opening H o .
  • Catheter 600 passes through aortic valve H AV into arterial vasculature (not shown).
  • Electrically conductive members 606 remain in contact with heart wall H w .
  • FIG. 8 schematically shows illustrative introducer 800 in access opening H o .
  • Introducer 800 may have been coaxially placed on catheter 600 .
  • Catheter 600 may be used to guide introducer 800 into place in access opening H o .
  • Introducer 800 may include elongated member 802 .
  • Elongated member 802 may include outer surface 804 .
  • Outer surface 804 may resist closure of access opening H o in heart wall H.
  • the pressure of heart wall H w on outer surface 804 may be sufficient to prevent the leakage of blood H b from interior H i of chamber H c between outer surface 804 and heart wall H w to exterior H ext of heart H.
  • the pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 804 and heart wall H w .
  • Introducer 800 may include one or more electrically conductive members such as representative electrically conductive member 806 .
  • One or more of electrically conductive members 806 may be supported by elongated member 802 .
  • One or more of electrically conductive members 806 may be supported by outer surface 804 .
  • One or more of electrically conductive members 806 may be used to provide electrical pulses to heart wall H w to change the contraction frequency.
  • One or more of electrically conductive members 806 may be placed in direct contact with heart wall H w to provide the electrical pulses.
  • Introducer 800 may advance and withdraw longitudinally through access opening H o . Electrically conductive members 806 remain in contact with heart wall H w .
  • Introducer 800 may include valve 808 .
  • Valve 808 may include an orifice that deforms around an instrument that passes through introducer 800 . The instrument may thus be passed through valve 808 while valve 808 reduces or eliminates the loss of blood H b through introducer 800 .
  • Introducer 800 may be used in conjunction with obliterator 810 .
  • Obliterator 810 may have one or more features in common with obliterator 101 .
  • FIG. 9 shows introducer 800 in opening H o after withdrawal of catheter 600 .
  • balloons 900 and 902 may be present adjacent distal and proximal contacts, 904 and 906 , respectively, between outer surface 804 and heart wall H.
  • the balloons may interfere with the leakage of blood from heart H.
  • FIG. 10 shows prosthetic valve V, which has been delivered through introducer 800 and positioned in aortic valve annulus H A .
  • Annulus H A may have resulted from the resection of aortic valve H AV (shown in FIG. 9 ).
  • the resection may have been performed by deploying resection tools through introducer 800 .
  • Valve V may be delivered at the distal tip of a catheter (not shown) such as 600 (shown in FIG. 6 ).
  • Valve V may be delivered at the distal tip of the catheter in a procedure that does not involve introducer 800 .
  • valve V may fixed to the tip of catheter 600 and advanced distally as catheter 600 is advanced as shown in FIGS. 6 and 7 .
  • FIG. 10 shows valve delivery catheter 1000 extending through introducer 800 , although valve delivery catheter 1000 may have one or more features in common with catheter 600 and may be used without an introducer.
  • Catheter 1000 may be advanced and withdrawn through access opening 600 to first deploy proximal fitting 1002 of heart valve V, then stretch distal end 1004 of heart valve V distal of coronary sinuses H c S and secure distal end 1004 to aortic wall H AW . This may properly configure commissure support tissue 1006 to function.
  • Balloon 1008 may be used to radially expand base ring 1010 of valve V.
  • electrically conductive members 606 may provide pulses to heart wall H w while catheter 600 is advanced and withdrawn in connection with the deployment of valve V and the withdrawal from heart wall H w of catheter 600 .
  • FIG. 11 shows valve V in place in aortic rim H AR .
  • Introducer 800 and wire W have been withdrawn from heart wall H w .
  • Electrically conductive members 806 may have provided pulses to heart wall H w during withdrawal of introducer 800 from heart wall H w .
  • Closure device 1100 may be deployed in access opening H o .
  • Closure device 1100 may provide a seal for access opening H o and may prevent blood H b from exiting access opening H o .
  • the seal may be a temporary seal.
  • the seal may be a permanent seal.
  • Closure device 1100 may be deployed through introducer 800 .
  • Closure device 1100 may be deployed without the use of introducer 800 .
  • Closure device 1100 may include distal end 1102 .
  • Closure device may include stem 1104 .
  • Closure device may include proximal end 1106 .
  • Closure device may include one or more electrically conductive members, such as 1108 , 1110 , 1112 and 1114 .
  • Leads such as 1120 , 1122 , 1124 and 1126 may provide the electrically conductive members with electrical pulses for conduction to the heart.
  • FIG. 12 shows, in a view similar to that which would be seen along lines 12 - 12 (shown in FIG. 1 ), an illustrative partial cross-section of instrument 1200 .
  • Instrument 1200 may have one or more features in common with instrument 100 , needle 300 , catheter 600 or introducer 800 .
  • Instrument 1200 may include elongated member 1202 .
  • Elongated member 1202 may include outer surface 1204 .
  • Instrument 1200 may include one or more electrically conductive members such as representative electrically conductive member 1206 .
  • One or more of electrically conductive members 1206 may be used to provide electrical pulses to heart wall H w to change the contraction frequency.
  • One or more of electrically conductive members 1206 may be placed in direct contact with heart wall H w to provide the electrical pulses.
  • the energy may be supplied by leads such as 1208 from a source such as 110 (shown in FIG. 1 ).
  • the energy may be supplied wirelessly from the source 110 .
  • Electrically insulating members 1210 may electrically insulate electrically conducting members 1206 from elongated member 1202 . When elongated member 1202 is an electrical insulator, electrically insulating members 1210 may not be included.
  • Instrument 1200 may include delivery lumen 1212 for delivering an instrument to the heart.
  • FIG. 13 shows, along lines 13 - 13 (shown in FIG. 12 ), a cross-section of instrument 1200 .
  • Electrically conductive members 1206 and electrically insulating members 1210 may be flush with outer surface 1204 of elongated member 1202 .
  • FIG. 14 shows, in a view similar to that along lines 14 - 14 (shown in FIG. 12 ), a cross-section of instrument 1400 , which may have one or more features in common with instrument 1200 .
  • Instrument 1400 may include elongated member 1402 .
  • Elongated member 1402 may include outer surface 1404 .
  • Instrument 1400 may include electrically conductive members 1406 and electrically insulating members 1410 .
  • Electrically conductive members 1406 may extend radially away from outer surface 1404 .
  • Electrically insulating members 1410 may be flush with outer surface 1404 .
  • electrically insulating members 1410 may not be included.
  • Instrument 1400 may include delivery lumen 1412 for delivering an instrument to the heart.
  • FIG. 15 shows, in a view similar to that which would be seen along lines 15 - 15 (shown in FIG. 1 ), an illustrative partial cross-section of instrument 1500 .
  • Instrument 1500 may have one or more features in common with instrument 100 , needle 300 , catheter 600 , introducer 800 , instrument 1200 or instrument 1300 .
  • Instrument 1500 may include elongated member 1502 .
  • Elongated member 1502 may include outer surface 1504 .
  • Instrument 1500 may include one or more electrically conductive members such as representative electrically conductive member 1506 .
  • One or more of electrically conductive members 1506 may be used to provide electrical pulses to heart wall H w to change the contraction frequency.
  • One or more of electrically conductive members 1506 may be placed in direct contact with heart wall H w to provide the electrical pulses.
  • the energy may be supplied by leads such as 1508 from a source such as 110 (shown in FIG. 1 ).
  • the energy may be supplied wirelessly from the source 110 .
  • Electrically insulating members 1510 may electrically insulate electrically conducting members 1506 from elongated member 1502 . When elongated member 1502 is an electrical insulator, electrically insulating members 1510 may not be included.
  • One or more of electrically conducting members 1506 and electrically insulating members 1510 may include tape.
  • One or more of electrically conducting members 1506 and electrically insulating members 1510 may include a thin film. The thin film may be deposited on outer surface 1504 . The thin film may deposited on electrically insulating members 1510 . The thin film may be printed lithographically.
  • Instrument 1500 may include delivery lumen 1512 for delivering an instrument to the heart.
  • FIG. 16 shows, along lines 16 - 16 (shown in FIG. 15 ), a cross-section of instrument 1500 .
  • FIG. 17 shows illustrative instrument 1700 .
  • Illustrative instrument 1700 may have one or more features in common with instrument 100 , needle 300 , catheter 600 , introducer 800 , instrument 1200 , instrument 1300 or instrument 1500 .
  • Instrument 1700 may include elongated member 1702 .
  • Elongated member 1702 may include outer surface 1704 .
  • Outer surface 1704 may resist closure of access opening H o in heart wall H w .
  • the pressure of heart wall H w on outer surface 1704 may be sufficient to prevent the leakage of blood H b from interior H i of chamber H ext between outer surface 1704 and heart wall H w to exterior H ext of heart H.
  • the pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 1704 and heart wall H w .
  • Instrument 1700 may include one or more electrically conductive members such as representative electrically conducting member 1706 .
  • One or more of electrically conductive members 1706 may be used to provide electrical pulses to heart wall H w to change the contraction frequency.
  • One or more of electrically conductive members 1706 may be placed in direct contact with heart wall H w to provide the electrical pulses.
  • the energy may be supplied via a cables such as 1708 .
  • Instrument 1700 may include an instrument delivery lumen (not shown). Instrument 1700 may include instrument introduction port 1712 . Instrument 1700 may include fluid exchange port 1714 .
  • FIG. 18 is a view of region 18 of instrument 1700 (shown in FIG. 17 ).
  • FIG. 19 shows illustrative electrically conductive member 1900 being deployed in myocardium H m of heart H. Electrically conductive member 1900 may be permanently deployed in myocardium H m . Electrically conductive member 1900 may be temporarily deployed in myocardium H m .
  • Electrically conductive member 1900 may be deployed via deployment lumen 1902 in elongated member 1904 .
  • Elongated member 1904 may be part of an instrument such as instrument 100 , needle 300 , catheter 600 , introducer 800 , instrument 1200 , instrument 1300 , instrument 1500 , instrument 1700 or instrument 1900 .
  • Elongated member 1904 may positioned by displacing flexible control link 1908 longitudinally along deployment lumen 1902 .
  • Flexible control link 1908 may be detachable from electrically conductive member 1900 to deploy electrically conductive member 1900 in heart H.
  • Conductor 1910 may supply the pulses to electrically conductive member 1900 .
  • Conductor 1910 may remain attached to electrically conductive member 1900 after control link 1908 is detached from electrically conductive member 1900 .
  • Flexible control link 1908 may be detachably attached to electrically conductive member 1900 via any suitable mechanism such as a key, threaded union, an interference fit, a snap fit, a snap fit with a spring-biased tang or any other suitable mechanism.
  • Electrically conductive member 1900 may include one or more anchoring mechanisms such as representative flexible barb 1914 or any other suitable anchoring mechanism or substance.
  • the anchoring system may include a spiral thread, circumferential ribs, epoxy, adhesive or any other suitable anchoring mechanism or substance.
  • FIG. 20 shows illustrative control catheter 2002 .
  • Flexible control link 1908 may run through control catheter 2002 .
  • Control catheter 2002 may include distal end 2004 that abuts or engages base 2006 of electrically conductive member 1900 .
  • Distal end 2004 may provide force to the base so that electrically conductive member 1900 can resist forces associated with the disengagement of flexible control link 1908 from electrically conductive member 1900 .
  • Control link 1908 may engage and disengage electrically conductive member 1900 via “T”-key 2008 in slot 2010 .
  • Slot 2012 in electrically conductive member 1900 may be keyed to accommodate passage of “T”-key 2008 .
  • FIG. 21 schematically shows illustrative introducer 2100 in access opening H o .
  • Introducer 2100 may have one or more features in common with instrument 100 , needle 300 , catheter 600 , introducer 800 , instrument 1200 , instrument 1300 , instrument 1500 or instrument 1700 .
  • Introducer 2100 may have been coaxially placed on catheter 600 .
  • Catheter 600 may be used to guide introducer 2100 into place in access opening H o .
  • Introducer 2100 may include elongated member 2102 .
  • Elongated member 2102 may include outer surface 2104 .
  • Outer surface 2104 may resist closure of access opening H o in heart wall H w .
  • the pressure of heart wall H w on outer surface 2104 may be sufficient to prevent the leakage of blood H b from interior H i of chamber H c between outer surface 2104 and heart wall H w to exterior H ext of heart H.
  • the pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 2104 and heart wall H w .
  • Introducer 2100 may include one or more electrically conductive members such as representative electrically conductive member 2106 .
  • One or more of electrically conductive members 2106 may be supported by elongated member 2102 .
  • One or more of electrically conductive members 2106 may be supported by outer surface 2104 .
  • One or more of electrically conductive members 2106 may be used to provide electrical pulses to heart wall H w to change the contraction frequency.
  • One or more of electrically conductive members 2106 may be placed in direct contact with heart wall H w to provide the electrical pulses.
  • Introducer 2100 may advance and withdraw longitudinally through access opening H o . Electrically conductive members 2106 remain in contact with heart wall H w .
  • Introducer 2100 may include valve 2108 .
  • Valve 2108 may include an orifice that deforms around an instrument that passes through introducer 2100 . The instrument may thus be passed through valve 2108 while valve 2108 reduces or eliminates the loss of blood H b through introducer 2100 .
  • Introducer 2100 may be used in conjunction with obliterator 2110 .
  • Obliterator 2110 may have one or more features in common with obliterator 101 or obliterator 810 .
  • Illustrative injection catheter 2110 may be provided coaxially about instrument 2100 .
  • Injection catheter 2110 may be configured to insert electrically conductive members in heart H.
  • Injection catheter 2110 may be configured to be provided coaxially about one or more of instrument 100 , needle 300 , catheter 600 , introducer 800 , instrument 1200 , instrument 1300 , instrument 1500 and instrument 1700 .
  • FIG. 22 shows in part a partial cross-sectional view of injection catheter 2110 about introducer 2100 .
  • Injection catheter 2210 may include distal end 2212 .
  • Distal end 2212 may be contoured to conform or partially conform to pericardium H p .
  • Injection catheter may include one or more deployment lumens such as representative deployment lumen 2214 .
  • Electrically conducting members such as representative electrically conducting member 2216 may be inserted in myocardium H m using deployment lumens such as representative deployment lumen 2214 .
  • Electrically conducting member 2216 may have one or more feature in common with electrically conducting member 2000 (shown in FIG. 20 ).
  • Injection catheter 2210 may include one or more flexible control link such as representative control link 2218 .
  • Flexible control link 2218 may have one or more features in common with flexible control link 2008 .
  • Injection catheter 2210 may include one or more conductors such as representative conductor 2220 .
  • Conductor 2220 may have one or more features in common with conductor 2010
  • FIG. 23 schematically shows illustrative access opening closure device 2300 .
  • Closure device 2300 may have one or more features in common with closure device 1100 (shown in FIG. 11 ).
  • Closure device 2300 may be inserted in access opening H o .
  • Closure device 2300 may include distal end 2302 , stem 2304 and proximal end 2306 .
  • One or both of distal end 2302 and proximal end 2306 may have a shape, such as a disc, a cone or a dome to rest flush against endocardium H e or pericardicum H p . The shape reduce or prevent the leakage of blood H b from heart interior H i .
  • One or more of distal end 2302 , stem 2304 and proximal end 2306 may include elastic material.
  • the elastic material may allow stem 2302 to be set in tension across heart wall H w .
  • the tension may compress distal edge 2308 against endocardium H e .
  • Closure device 2300 may be deployed in access opening H o by delivering distal end 2302 through a cannulated instrument, such as instrument 100 (shown in FIG. 1 ), when it is cannulated, through access opening H o to heart interior H i . While retaining proximal end 2306 , the distal tip of instrument 100 may be withdrawn from access opening H o and proximal end 2306 may be released in the heart exterior region H ext . Tension in closure device 2300 may then urge proximal end 2306 into position against heart H. Pericardium H p may be retracted so that proximal end 2306 is in contact with myocardium H m .
  • Closure device 2300 may include body 2310 .
  • Body 2310 may include some or all of distal end 2302 , stem 2304 and proximal end 2306 .
  • Body 2310 may include electrically insulating material such as a polymer that is less electrically conductive than metal or electrically conductive polymer.
  • Distal end 2302 may include one or more electrically conductive members such as representative conductive member 2312 . Electrically conductive member 2312 may extend around the circumference of distal end 2302 . Proximal end 2302 may include one or more electrically conductive members such as representative electrically conductive member 2314 . Electrically conductive member 2314 may extend around the circumference of distal end 2302 .
  • Stem 2302 may include one or more electrically conductive members such as representative conductive member 2316 .
  • the elastic material may allow stem 2302 to be set in radial compression against heart wall H. The compression may maintain electrically conductive member 2316 in contact with heart wall H. Electrically conductive member 2316 may have one or more features in common with electrically conductive member 106 of instrument 100 (shown in FIG. 1 ).
  • FIG. 24 shows a cross sectional view of closure device 2300 taken along lines 24 - 24 (shown in FIG. 23 ).
  • Electrically conductive members 2312 and 2314 may be in electrical communication with a source such as source 110 (shown in FIG. 1 ) via conductors 2416 and 2418 .
  • Electrically conductive member 2316 may be in electrical communication with a source such as source 110 (shown in FIG. 1 ) via conductor 2422 .
  • the conductors may lead out of closure device 2300 via ported seal 2420 .
  • the conductors may run in space 2424 , which may be a lumen.
  • FIG. 25 shows a cross-sectional view of closure device 2300 taken along lines 25 - 25 (shown in FIG. 24 ).
  • Electrically conductive member 2316 runs circumferentially around some or all of stem 2304 .
  • Conductor 2422 runs radially between space 2424 and electrically conductive member 2316 .
  • Conductor 2416 runs longitudinally through space 2424 .
  • FIG. 26 shows in cross section illustrative proximal end 2600 of a closure device such as 2300 (shown in FIG. 23 ).
  • Proximal end 2600 may have one or more features in common with proximal end 2306 (shown in FIG. 23 ).
  • Proximal end 2600 may include removable cap 2602 .
  • Cap 2602 may be connected to closure device body in recess 2604 .
  • Cap 2602 may be secured in recess 2604 by any suitable mechanism such as threads (not shown), a clasp (not shown), a suture (not shown), an interference fit with rib 2606 or any other suitable mechanism.
  • Cap 2602 may include one or more terminal pins such as representative pin 2608 .
  • Terminal pin 2608 may be in electrical communication distally with a source such as 110 (shown in FIG. 1 ).
  • Terminal pin 2608 may be inserted into receptacle 2610 .
  • Terminal pin 2608 may be in electrical communication with receptacle 2610 .
  • Receptacle 2610 may be in electrical communication with one or more conductors, such as conductor 2612 that lead to one or more electrically conducting members on body 2606 .
  • the electrically conducting members may have one or more features in common with the electrically conducting members of closure device 2300 (shown in FIG. 23 ).
  • Cap 2602 may be removed from distal end 2600 .
  • the closure device may be deployed in heart H after delivery of an instrument to interior H i of heart H.
  • the closure device may remain in heart H while a patient is under postoperative observation.
  • Cap 2602 may be removed.
  • the removal of cap 2602 may disconnect terminal pin 2608 from receptacle 2610 .
  • the closure device may thus be disconnected from a source such as 110 (shown in FIG. 1 ).
  • a replacement cap (not shown) may be installed in recess 2604 .
  • the replacement cap may have one or more non-conducting pins that mate with receptacles such as 4610 .
  • the replacement cap may seal against distal end 2600 to prevent fluids from interacting with receptacle 2610 .
  • One of the non-conducting pins may seal receptacle 2610 .
  • the replacement cap may be permanently installed in recess 2604 .
  • the replacement cap may be removably installed in recess 2604 .
  • a cap such as 2602 may be installed after removal of the replacement cap to reestablish electrical communication between one or more of the electrically conducting members and a source such as 110 (shown in FIG. 1 ).
  • FIG. 27 schematically shows intracardiac ultrasound receiver 2700 .
  • Intracardiac ultrasound receiver 2700 may be placed in the right atrium (not shown) via a femoral vein (not shown).
  • Intravascular ultrasound receiver (“IVUS”) 2702 may be delivered into chamber H c over guidewire.
  • IVUS 2702 may be positioned in a valve such as aortic valve H AV .
  • Extracorporeal X-ray-based radiographic and fluoroscopic devices may be used map and visualize anatomy and instrumentation related to the procedure.
  • IVUS 2702 may be used to locate aortic valve H AV , sino-tubular junction H STJ , and brachio-cephalic trunk H BCT .
  • Any suitable analytical mapping platform such as that available under the trademark ACUNAV from Biosense Webster, Inc., of Diamond Bar, Calif., may be used to track IVUS 2702 and determine the location of the anatomical features.
  • the analytical mapping platform may be used in conjunction with fluoroscopy.
  • a radioopaque marker may be placed on the anatomical features or, in locations corresponding to the anatomical features, on the patient's skin or the heart's surface so that extracorporeal fluoroscopy can later be used to relocate the features.
  • IVUS 2702 along with the analytical mapping platform and fluoroscopy equipment may be used to take measurements of the diseased valve.
  • a camera may be inserted through the apparatus into chamber H c .
  • a transparent balloon (filled with a transparent fluid such as water) may be positioned in front of the camera. The camera and liquid-filled balloon are pushed against the surface that the surgeon wishes to view. The transparent balloon displaces blood from the camera's line of sight such that an image of what the camera sees through the balloon is transmitted to the surgeon.
  • One or more signals from the visualization receivers and devices may be transmitted to a display such as display 120 (shown in FIG. 1 ).
  • FIG. 28 shows that an instrument such as 800 (shown in FIG. 8 ) may deliver to the ascending aorta, near coronary sinuses A CS , illustrative embolic one or more embolic protection devices such as EPD 1 , EPD 2 and EPD 3 along guidewires W 1 , W 2 and W 3 .
  • EPD 1 , EPD 2 and EPD 3 may include a filtering mesh or net made from any suitable material. The chosen material should be able to be collapsed, expanded, and re-collapsed multiple times.
  • Embolic protection devices may be delivered through introducer 800 for placement in the brachiocephalic, left common carotid, and left subclavian arteries of the aortic arch (not shown).
  • Introducer 800 may be used to deliver a valve delivery system, such as a catheter on which is mounted an expandable valve, or a temporary valve device (not shown) to a suitable location in the vasculature.
  • a valve delivery system such as a catheter on which is mounted an expandable valve, or a temporary valve device (not shown)
  • a temporary valve device not shown
  • H o wever, it is possible to temporarily replace the aortic valve function with a device placed in the descending aorta.
  • Such a placement may have the disadvantage of causing the heart to work harder, but such placements have been proven acceptable in previous surgical procedures.
  • Introducer 800 may be used to deliver a blood pump such as a ventricular assist device (“VAD”; not shown).
  • VAD ventricular assist device
  • the VAD or other temporary pump device may be used to support the heart's natural function while a native valve is being resected or repaired.
  • FIG. 29 shows that introducer 800 may be used to deliver balloon-actuated resection tool 2900 to heart H.
  • Tool 2900 may include balloons 2902 and 2904 .
  • Balloons 2902 and 2904 may drive together radially expanded cutting edges 2906 and 2908 to resect a valve such as aortic valve H AV .
  • FIG. 30 shows illustrative ablation chamber 3000 that may be delivered to heart H using introducer 800 .
  • Ablation chamber 3000 is shown deployed in aorta A.
  • Ablation chamber 3000 may include distal containment barrier 3004 and proximal containment barrier 3006 .
  • Cather C may have one or more lumens.
  • One or more of the lumens may permit blood circulation through lumen 3007 .
  • One or more of the lumens may supply outlet 3008 with an ablation chemical.
  • One or more of the lumens may receive ablation material from inlet 3010 .
  • a laser ablation device (not shown) may be delivered to heart H using introducer 800 .
  • FIG. 31 shows illustrative fluid delivery balloon assembly 3100 that may be delivered to heart H using introducer 800 .
  • Assembly 3100 may be supported by one or both of catheter 3102 and wire 3104 .
  • Assembly 3100 may include one or more cannulated needles such as representative cannulated needle 3106 .
  • Cannulated needle 3106 may deliver a fluid to heart H.
  • the fluid may include glue.
  • Needle 3106 may penetrate aortic dissection H AD such that a tips of needle 3106 is exposed in void H void .
  • the glue may be a biologically compatible glue.
  • the glue may be injected through needle 3106 via a glue delivery lumen (not shown) in catheter 3102 . Inflation of a balloon in assembly 3100 may ensure that dissection H AD is securely affixed to aorta wall H AW by the biologically compatible glue.
  • FIG. 32 shows illustrative fluid filled bolster 3200 that may be delivered to heart H using introducer 800 .
  • Bolster 3200 may be deployed through catheter 3202 .
  • Bolster 3200 may be used to repair, stabilize or fill in left ventricular aneurysm H LVA or any other aneurysm.
  • Bolster 3200 may be installed in aneurysm H LVA using the glue, sutures, clips or by any other suitable mounting technique.
  • FIG. 33 shows illustrative repair device 3302 that may be delivered to heart H using introducer 800 .
  • Device 3302 may be deployed through catheter 3303 .
  • Device 3302 may include one or more hooks such as 3304 and 3306 .
  • Aneurysm H LVA may be repaired by using the hooks to pull ends of aneurysm H LVA together.
  • Hooks 3304 and 3306 may grasp the interior of heart H at extremes of aneurysm H LVA and then draw aneurysm H LVA closed. Any suitable technique can be used to secure aneurysm H LVA in the closed position (e.g., biologically compatible glue, surgical staples, mechanically placed sutures, etc.).
  • repair device 3302 may be withdrawn from the patient.
  • FIG. 34 shows illustrative embolic filter 3400 , temporary valve 3402 and VAD 3404 that may be delivered to heart H using introducer 800 (shown in FIG. 8 ).
  • One or more of embolic filter 3400 , temporary valve 3402 and VAD 3404 may be positioned using wire 3406 .
  • Wire 3406 may be delivered to heart chamber H c using introducer 800 .
  • One or more of embolic filter 3400 , temporary valve 3402 and VAD 3404 may be positioned distal aortic valve H AV in in ascending aorta H AA .
  • Embolic filter 3400 may be configured to protect coronary arteries H CA .
  • FIG. 35 shows illustrative endoprosthesis 3500 that may be delivered to heart H using introducer 800 (shown in FIG. 8 ).
  • Endoprosthesis 3500 is illustrated as being configured for deployment in aortic arch H arch , but endoprothesis 3500 may be configured to treat many different anatomical structure.
  • Endoprosthesis 3500 may include arms such as 3502 that extend into the brachiocephalic artery, left common carotid artery, and left subclavian artery 408 .
  • Endoprosthesis 3500 may be placed using a guidewire that may pass through introducer 800 and engage a hole such as 3504 .
  • Endoprosthesis 3500 and arm 3502 may be radially expanded once endoprosthesis 3500 is properly positioned.
  • FIG. 36 shows a cross section of illustrative needle assembly 3600 .
  • Needle assembly 3600 may include needle 3601 .
  • Illustrative needle 3601 may have one or more features in common with instrument 100 , needle 300 , catheter 600 , introducer 800 , instrument 1200 , instrument 1300 , instrument 1500 or instrument 1700 .
  • Needle assembly 3600 may include firing tube 3603 .
  • Firing tube 3603 may include lumen 3605 .
  • a firing apparatus (which may include firing tube 3603 and peg 3616 , but otherwise is not shown) may act on firing post 3616 to eject needle 3601 from tube 3603 and into myocardium H m (not shown).
  • the insertion of needle 3601 may be the establishment of an access opening such as H o (shown in FIG. 1 ).
  • Distal end 3618 of firing tube 3603 may be placed adjacent or within an intercostal region. Firing tube may be angled toward heart H m . Distal end 3618 of firing tube 3603 may be placed on heart H m . Distal end 3618 of firing tube 3603 may be placed on the skin.
  • the firing apparatus may be used to insert needle 3601 into myocardium H m is a surgical setting in which a surface of heart (H) is exposed, in a percutaneous setting in which access to heart H is provided by a small incision or in a strictly percutaneous setting in which needle 3601 is ejected from tube 3603 through the skin and into myocardium H m .
  • Needle 3601 may include elongated member 3602 .
  • Elongated member 3602 may be cannulated.
  • Elongated member 3602 may be uncannulated.
  • Elongated member may not include a delivery lumen.
  • Elongated member 3602 may include outer surface 3604 .
  • Outer surface 3604 may resist closure of access opening H o (shown in FIG. 1 ) in heart wall H w (shown in FIG. 1 ).
  • the pressure of heart wall H w on outer surface 3604 may be sufficient to prevent the leakage of blood H b from interior H i of chamber H c between outer surface 3604 and heart wall H w to exterior H ext of heart H.
  • the pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 3604 and heart wall H w .
  • Needle 3601 may include one or more electrically conductive members such as 3606 .
  • One or more of electrically conductive members 3606 may be supported by elongated member 3602 .
  • One or more of electrically conductive members 3606 may be used to provide electrical pulses to heart wall H w to change the contraction frequency.
  • One or more of electrically conductive members 3606 may be placed in direct contact with heart wall H w to provide the electrical pulses.
  • the energy may be supplied via a cable such as 3608 from a source such as 110 (shown in FIG. 1 ).
  • the energy may be supplied wirelessly from source 110 .
  • An electrically conductive member may be placed on the skin or on the heart surface to complement current supplied by electrically conductive member 3606 .
  • Electrically insulating members 3610 may electrically insulate electrically conducting members 3606 from elongated member 3602 . When elongated member 3602 is an electrical insulator, electrically insulating members 3610 may not be included.
  • Cable 3608 may be wound about firing post 3612 .
  • a driving force may be delivered to receptacle 3614 inside post 3612 .
  • the driving force may be supplied by peg 3616 .
  • Peg 3616 may be driven by any suitable mechanism.
  • peg 3616 may be driven by a spring or compressed gas or by hand.
  • Peg 3616 may drive needle 3612 longitudinally and allow needle 3612 to disengage from peg 3616 and penetrate myocardium H m .
  • Needle 3601 may be driven directly by the spring or compressed gas or by the hand.
  • cable 3608 may unravel from drive post 3612 .
  • a practitioner may pull on cable 3608 to evaluate whether needle 3612 has become lodged in myocardium H m .
  • Needle assembly 3600 may include more than one firing tube. Each firing tube may include one needle. When each needle includes one electrically conductive member, the two or more needles may provide current to different locations in the heart. The different locations may be proximate each other, for example, within 1-5 needle diameters of each other. The different locations may be apart from each other, for example, within 6-10, 10-20 or more needle diameters from each other.
  • One or more additional electrically conductive members may have a distal end that is placed in electrical communication with epidermal tissue on the body in which the heart is disposed.
  • the one or more additional electrically conductive members may have a proximal end that is in electrical communication with control panel 3612 .
  • FIG. 37 shows, along lines 37 - 37 (shown in FIG. 36 ), a cross-section of needle 3601 .
  • Electrically conductive members 3606 and electrically insulating members 3610 may be flush with outer surface 3604 of elongated member 3602 .
  • FIG. 38 shows, in a view similar to that along lines 36 - 36 (shown in FIG. 36 ), a cross-section of instrument 3800 , which may have one or more features in common with needle 3601 .
  • Instrument 3800 may include elongated member 3802 .
  • Elongated member 3802 may include outer surface 3804 .
  • Instrument 3800 may include electrically conductive members 3806 and electrically insulating members 3810 .
  • Electrically conductive members 3806 may extend radially away from outer surface 3804 .
  • Electrically insulating members 3810 may be flush with outer surface 3804 .
  • electrically insulating members 3810 may not be included.

Abstract

Apparatus and methods for pacing the heart. The apparatus may include, and the methods may involve, an elongated member having: a delivery lumen that is configured to traverse the heart wall, the lumen having a proximal opening for receiving the instrument and a distal opening for deploying the instrument; and an electrically conductive member that is configured to deliver to the heart wall a current that modifies a contraction frequency. The apparatus may include an access opening closure device that has: a distal end that is configured to be disposed interior the heart and contact endocardial tissue adjacent the access opening; and a proximal end that is configured to be disposed exterior the heart and contact heart tissue adjacent the access opening; and an electrode that is configured to discharge electrical energy into the heart wall to change the frequency. The apparatus may include an injectable needle pacing electrode.

Description

    CROSS-REFERENCE TO OTHER APPLICATIONS
  • This application is a nonprovisional of U.S. Application No. 61/631,639 which was filed on Jan. 9, 2012, and is hereby incorporated by reference herein in its entirety.
  • BACKGROUND
  • Rapid pacing of the heart is often used during therapeutic activities in the heart. The rapid pacing may reduce blood pressure and flow in the heart. This may reduce stress on heart anatomy when therapeutic instruments or prostheses are present in the heart and may interfere with normal blood flow through the heart. For example, when instruments or prostheses are “upstream” from a valve and partially or wholly obstruct flow through the valve, destructive stress can be transmitted to the valve and adjacent tissue.
  • Rapid pacing of the heart often requires applying current from at least two electrodes. Often, a first electrode is placed in contact with the heart and a second electrode is place in contact with the patient's skin. Open surgery provides easy access to heart tissue for deployment of an electrode. Smaller access incisions that are used in percutaneous procedures, however, reduce access to the heart tissue and make it more difficult to apply an electrode to the heart surface or to retain the electrode on the heart surface during the procedure.
  • In some procedures, the heart surface electrode may be replaced by a temporary venous pacing lead that is deployed in a chamber of the heart, for example, a right atrium or a right ventricle. The pacing lead may be deployed via a neck, arm or leg vein.
  • Temporary venous pacing may require intervention that is not required by placement of the heart surface electrode.
  • It would be desirable to provide apparatus and methods for rapid pacing of the heart in connection with percutaneous procedures.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The objects and advantages of the invention will be apparent upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which like reference characters refer to like parts throughout, and in which:
  • FIG. 1 shows apparatus in accordance with the principles of the invention along with illustrative anatomy, in cross-section, in connection with which the invention may be practiced;
  • FIG. 2 is a cross-sectional view, oriented like that along lines 2-2 (shown in FIG. 1), of other apparatus in accordance with the principles of the invention along with anatomy.
  • FIG. 3 shows other apparatus in accordance with the principles of the invention along with anatomy;
  • FIG. 4 shows the apparatus and anatomy of FIG. 3 when the apparatus is in a position different from that shown in FIG. 3;
  • FIG. 5 shows the apparatus and anatomy of FIG. 3 when the apparatus is in a different position and a different configuration from the position and configuration shown in FIG. 3;
  • FIG. 6 shows still other apparatus in accordance with the principles of the invention along with anatomy;
  • FIG. 7 shows the apparatus of FIG. 6 when the apparatus in a different position from the position shown in FIG. 6;
  • FIG. 8 shows yet other apparatus in accordance with the principles of the invention along with anatomy;
  • FIG. 9 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy.
  • FIG. 10 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy;
  • FIG. 11 shows the apparatus of FIG. 8 along with yet other apparatus in accordance with the principles of the invention, and yet other apparatus, and anatomy;
  • FIG. 12 shows, in partial cross-section, oriented like that along lines 12-12 (shown in FIG. 1), of other apparatus in accordance with the principles of the invention;
  • FIG. 13 shows a cross-section taken along lines 13-13 (shown in FIG. 12) of the apparatus shown in FIG. 12;
  • FIG. 14 shows a cross-section, oriented like that along lines 13-13 (shown in FIG. 12), of other apparatus in accordance with the principles of the invention;
  • FIG. 15 shows, in partial cross-section, oriented like that along lines 15-15 (shown in FIG. 1), of other apparatus in accordance with the principles of the invention;
  • FIG. 16 shows a cross-section taken along lines 16-16 (shown in FIG. 15) of the apparatus shown in FIG. 15;
  • FIG. 17 shows yet other apparatus in accordance with the principles of the invention along with anatomy;
  • FIG. 18 shows a portion, indicated in FIG. 17 as “18,” of the apparatus shown in FIG. 17;
  • FIG. 19 shows, in partial cross-section, yet other apparatus in accordance with the principles of the invention along with anatomy;
  • FIG. 20 shows a portion, indicated in FIG. 20 as “19,” of the apparatus shown in FIG. 19;
  • FIG. 21 shows yet other apparatus in accordance with the principles of the invention along with anatomy;
  • FIG. 22 shows a cross-section taken along lines 22-22 (shown in FIG. 21) of the apparatus shown in FIG. 21 along with anatomy;
  • FIG. 23 shows yet other apparatus in accordance with the principles of the invention along with anatomy;
  • FIG. 24 shows a cross-section taken along lines 24-24 (shown in FIG. 23) of the apparatus shown in FIG. 23 along with anatomy;
  • FIG. 25 shows a cross-section taken along lines 25-25 (shown in FIG. 24) of the apparatus shown in FIG. 23 along with anatomy;
  • FIG. 26 shows, in partial cross-section, yet other apparatus in accordance with the principles of the invention, that corresponds to a portion of the apparatus shown in FIG. 23 and indicated in FIG. 24 as “26;”
  • FIG. 27 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy;
  • FIG. 28 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy;
  • FIG. 29 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy;
  • FIG. 30 shows yet other apparatus that may be used in accordance with the principles of the invention;
  • FIG. 31 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy;
  • FIG. 32 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy;
  • FIG. 33 shows the apparatus of FIG. 8 along with yet other apparatus and anatomy;
  • FIG. 34 shows yet other apparatus that may be used in accordance with the principles of the invention;
  • FIG. 35 shows yet other apparatus that may be used in accordance with the principles of the invention;
  • FIG. 36 shows, in partial cross-section, yet other apparatus in accordance with the principles of the invention;
  • FIG. 37 shows a cross-section taken along lines 37-37 (shown in FIG. 36) of the apparatus shown in FIG. 36; and
  • FIG. 38 shows a cross-section, oriented like that along lines 37-37 (shown in FIG. 36), of other apparatus in accordance with the principles of the invention.
  • DETAILED DESCRIPTION
  • Apparatus and method for delivering an instrument through an access opening in an exterior heart wall are provided. The apparatus may include an elongated member. The elongated member may include a delivery lumen that is configured to traverse the heart wall. The lumen may have a proximal opening for receiving the instrument and a distal opening for deploying the instrument. The apparatus may include an outer surface that is configured to maintain the access opening. The apparatus may include an electrically conductive member. The electrically conductive member may be supported by the elongated member. The electrically conductive member may be configured to deliver to the heart wall a current that modifies a contraction frequency of the heart. The apparatus may include one, two, three, four, 10 or more, or any suitable number of electrically conductive members. The electrically conductive member may be an electrode.
  • The electrically conductive member may be used to provide current to the heart in conjunction with another electrically conductive member that is placed elsewhere in the heart, on the heart, or on the patient's skin and also provides pacing current to the patient's tissue.
  • The elongated member may include any suitable biocompatible material such as polymer, stainless steel, nickel titanium alloy or any other suitable material.
  • The apparatus may include, for each electrically conductive member, a current supply lead. The current supply lead may receive one or more cardiac pacing signals from a cardiac pacing signal generator. A connector may be provided for placing the current supply lead in electrical communication with the cardiac pacing signal generator. The cardiac pacing signal generator may include any suitable pacing device.
  • In some procedures, more than one of the apparatus may be used together. For example, a first instrument having electrically conductive members for transferring pulses to the heart and a second instrument having electrically conductive members for transferring pulses to the heart may be coaxially arranged, the first inside the second. The first instrument may be extend from the distal end of the second instrument and be advanced into the myocardium to perform a first procedure. During the first procedure, pulses may be transferred to the heart from the first instrument.
  • After the first procedure, the second instrument may be advance along the first instrument into the myocardium. When the second instrument advances into the myocardium, pulses may be transferred to the heart from the second instrument. A current switch may be provided to transfer electrical energy from the first instrument to the second instrument. The current switch may analyze an electrical characteristic of one or both of the first and second instruments to detect the succession of the second instrument in the access opening. The current switch may deactivate the first instrument and activate the second instrument upon or about the time of the succession. The electrical characteristic may include a continuity. The electrical characteristic may include an impedance.
  • Table 1 lists illustrative instruments that may be delivered using the apparatus.
  • TABLE 1
    Illustrative instruments that may be delivered using the apparatus.
    Illustrative instrument
    Ablation catheter
    Access closure device
    Aneurysm sealing device
    Aortic endostent
    Catheter
    Coronary stent
    Decalcification tool
    Defibrillator
    Delivery system
    Embolic protection device
    Embolism preventer
    Endoprosthesis
    Heart assist device
    Heart valve
    Heat sink
    Heat source
    Introducer
    Microwave emitter
    Needle
    Occluder device
    Pacemaker
    Plug tool
    Radio frequency radiation emitter
    Valve
    Valve reconstruction tool (e.g., clip)
    Valve removal tool
    Wire
  • Table 2 lists illustrative procedures that may be carried out using the apparatus.
  • TABLE 2
    Illustrative procedures that may be carried out using the apparatus.
    Illustrative procedure
    Aneurysm repair
    Cardiac defibrillation
    Cardiac pacing
    Coronary dilatation
    Coronary stenting
    Decalcification of cardiac structures
    Endocardiac arrhytHmia mapping
    Heart and hemodynamic support
    Heart valve reconstruction
    Heart valve repair
    Hemodynamic diagnostic assessments
    Hemodynamic recording
    Removal of hypertrophic obstructions (obstructions distal to a heart valve)
    Repair dissected blood vessel
    Repair ruptured blood vessel
    Replacement of dissected blood vessel
    Replacement of ruptured blood vessel
    Resynchronization therapy
    Stemcell therapy
    Transcatheter valve implantation
    Transcatheter valve insertion
    Transcatheter valve replacement
    Treatment of subvalvular stenosis (an obstruction proximal to a heart
    valve)
    Ventricular arrhytHmia repair
  • The electrically conductive member may be configured to provide to the heart wall a series of pulses. The pulses may be quantified by pacing parameters. The pacing parameters may include voltage, current, energy, duration, pulse frequency, maxima and minima thereof, and any other suitable pacing parameters.
  • Table 3 shows illustrative ranges of some pacing parameters.
  • TABLE 3
    Illustrative ranges of pulse current.
    Current Pulse duration Pulse frequency
    From To From To From To
    about about about about about about
    (mA) (mA) (ms) (ms) (Hz) (Hz)
    0.01 0.05 0.01 0.05 1 3
    0.05 0.1 0.05 0.1 3 10
    0.1 1 0.1 1 10 30
    1 3 1 3 30 60
    3 10 3 10 60 100
    10 20 10 20 100 130
    20 30 20 40 130 160
    30 40 40 60 160 200
    40 50 60 80 200 230
    50 60 80 100 230 260
    60 100 100 200 260 300
  • Each pulse may carry from about 0.1 to about 40 milliamp (“mA”). Each pulse may have a duration that is in the range of about 0.1 to about 100 millisecond (“ms”). The pulses may be delivered with a frequency of about 10 to about 300 pulses per second.
  • The electrically conductive member may include copper, silver, gold, platinum, polymer or any other suitable conductive material. The electrically conductive member may include conductive wire, tape, foil, sheet, rod, bar, tube, shot or any other suitable form.
  • The electrically conductive member may be configured to be in direct contact with the heart wall. The electrically conductive member may be configured to be in indirect contact with the heart wall. The electronically conductive member may rest upon the outer surface. The electronically conductive member may be partially or wholly recessed into the elongated member. The electronically conductive member may be partially or wholly recessed relative to the outer surface into the elongated member.
  • The outer surface may be configured to slide through the access opening. When the outer surface slides through the access opening, the distal opening may displace from a first location to a second location. The first location may be in the heart, in a first chamber of the heart or in the vasculature. The second location may be in the heart, in a first chamber of the heart, in a second chamber of the heart or in the vasculature. The first chamber may be an aorta or a ventricle. The second chamber may be an aorta or a ventricle. The vasculature may include an artery. The vasculature may include a vein. The artery may be a pulmonary artery, a carotid artery, a coronary artery or any other suitable artery. The vein may a vena cava, a pulmonary vein, a coronary vein or any other suitable vein.
  • The electrically conductive member may be configured to slide through the access opening while the electrically conductive delivers the current to the heart wall. The electrically conductive member may be configured to be in direct contact with the heart wall while the electrically conductive member slides through the access opening. Contact between the electrically conductive member and the heart wall may be largely independent of positioning of the elongated member in the heart wall.
  • The apparatus may include an antenna that is supported by the elongated member and is configured to sense a native cardiac electric field in a chamber on the interior side of the heart wall. The antenna may communicate a corresponding native cardiac signal to a receiver exterior the heart wall. The receiver may be part of an electrocardiograph device. The antenna may communicate the cardiac signal via a transmission line. The antenna may communicate the cardiac signal wirelessly.
  • The apparatus may include a pressure sensor. The pressure sensor may be supported by the elongated member. The pressure sensor may be supported by the electrically conductive member. The pressure sensor may be configured to sense a pressure in the chamber. The pressure sensor may be configured to sense a pressure in the heart wall. The pressure sensor may be configured to transmit a corresponding pressure signal to a receiver exterior the heart wall. The antenna may communicate the pressure signal via a transmission line. The antenna may communicate the pressure signal wirelessly.
  • The apparatus may include a chemical sensor. The chemical sensor may be supported by the elongated member. The chemical sensor may be supported by the electrically conductive member. The chemical sensor may be configured to measure chemical values such as, for example, pH, lactate, cardiac enzymes, electrolytes. The chemical sensor may be configured to transmit a corresponding signal to a receiver exterior the heart wall. The chemical sensor may transmit the chemical signal via a transmission line. The chemical sensor may transmit the chemical signal wirelessly.
  • The chemical sensor may be calibrated to sense a chemical species. The species may be present in a chamber interior the heart wall. The species may be present at a myocardial tissue surface that is exposed in a heart wall access opening and transmit a corresponding chemical signal to a receiver exterior the heart wall.
  • The chemical sensor may detect the chemical value based on conductivity of the heart wall. The chemical sensor may detect the chemical value based on capacitance of the heart wall. The chemical sensor may detect the chemical value based on an electrical potential of the heart wall. The chemical sensor may include a porous layer. The chemical sensor may detect the chemical value based on conductivity of the porous layer. The chemical sensor may detect the chemical value based on capacitance of the porous layer. The chemical sensor may detect the chemical value based on an electrical potential of the porous layer.
  • The apparatus may include a processor that is configured to change a pacing parameter, for example, a frequency of the current based on the native cardiac signal. The processor may be configured to change the pacing parameter based on one or more pressure signal. The processor may be configured to change the pacing parameter based on one or more chemical signal.
  • The outer surface may apply pressure to the heart wall. The pressure may be sufficient to prevent blood transmission between the outer surface and the heart wall. The outer surface may apply contact pressure to the heart wall. The pressure may substantially prevent blood leakage between the outer surface and the heart wall by resisting pressure from the heart muscle upon the outer surface. The blood transmission may be prevented in the absence of a sealing element, proximate the access opening, on an interior side of the heart wall.
  • The elongated member may be configured to be maintained in a position, relative to the access opening, without an anchor that fixes the elongated member to the heart wall. When the elongated member is maintained in the position, it may be maintained such that it counters pressure of blood inside the heart.
  • The elongated member may include a proximal portion that is configured to be grasped by any suitable stabilization structure. The elongated member may have a longitudinal position, relative to the access opening, that is maintained primarily by the structure. The elongated member may have a longitudinal position, relative to the access opening, that is maintained exclusively by the structure. The structure may be a human hand. The structure may be a robotic manipulator.
  • The electrically conductive member may be configured to be released from the elongated member and inserted in the heart wall. The electrically conductive member may be inserted into the endocardium. The electrically conductive member may be inserted into the myocardium. The electrically conductive member may be inserted into the pericardium. The electrically conductive member may be fixed onto the endocardium. The electrically conductive member may be fixed onto the myocardium. The electrically conductive member may be fixed onto the pericardium.
  • The electrically conductive member may be anchored in the heart wall. The electrically conductive member may be anchored by a barb, a coil or any other suitable anchor. The electrically conductive member may be a wire. The wire may have a distal end that is driven into the heart wall. The electrically conductive member may be configured to be released from the elongated member and placed on the heart wall. The electrically conductive member may be left in place in the heart wall after removal of the elongated member from the access opening. The electrically conductive member may later be removed from the heart.
  • The elongated member may include a deployment lumen that is configured to direct the electrically conductive member into the heart wall. The elongated member may include an annular wall about the delivery lumen. The deployment lumen may run longitudinally within the annular wall. The deployment lumen may terminate at an orifice in the outer surface.
  • The elongated member may not include a deployment lumen. For example, when the elongated member is solid, as in a wire or a non-cannulated rod, the elongated member may not include a deployment lumen.
  • The wire may be part of a delivery system for delivering a prosthetic valve into the heart. When the wire is part of the delivery system, the prosthetic valve may be crimped onto a distal tip of the wire. The wire, with the valve, may be inserted into the access opening. The outer surface of the wire may be in contact with the heart wall. The contact may be direct contact. The wire, with the valve, may be inserted through the access opening within a sheath. The sheath may maintain the valve in an unexpanded state until the valve is in position for deployment. The sheath may be withdrawn proximally to allow a distal end of the valve to expand and engage heart anatomy. Further withdrawal of the sheath may allow a proximal end of the valve to expand and engage heart anatomy.
  • The wire, with the valve, may be inserted through an introducer. The introducer may have an outer surface that is in contact with the heart wall. The contact may be direct contact.
  • The apparatus may include one, two, three, four, 10 or more, or any suitable number of deployment lumens. Each of the deployment lumens may correspond to one or more electrically conductive members.
  • The elongated member may include a distal surface that is configured to abut pericardial tissue adjacent the access opening. The deployment lumen may terminate at an orifice in the distal surface.
  • The apparatus may include a control link. The control link may be configured to displace the electrically conductive member along the deployment lumen and into the heart wall. The control link may be configured to detach from the electrically conductive member when the electrically conductive member is lodged in the heart wall.
  • The control link may urge the electrically conductive member by contacting the electrically conductive member at a location on the electrically conductive member that is distal a portion of the electrically conductive member that initially engages the heart wall. The control link may urge the electrically conductive member by contacting the electrically conductive member at a location on the electrically conductive member that is proximal a portion of the electrically conductive member that initially engages the heart wall.
  • The apparatus may include a conductor that is attached to the electrically conductive member and runs proximally from the electrically conductive member through the deployment lumen.
  • The apparatus may include a second deployment lumen. The second deployment lumen may be configured to direct the electrically conductive member into the heart wall. The second deployment lumen may run longitudinally, with respect to the elongated member, within an annular wall about the delivery lumen. The second deployment lumen may terminate at an orifice in the outer surface.
  • The apparatus may include a second electrically conductive member that is supported by the elongated member. The second electrically conductive member may be configured to deliver to the heart wall a current that modifies the contraction frequency.
  • The electrically conductive member may be embedded in the outer surface. The electrically conductive member may be substantially flush with the outer surface. The electrically conductive member may extend away from the outer surface. The electrically conductive member may extend radially, relative to a longitudinal axis of the elongated member, away from the outer surface.
  • The apparatus may include a blood retention diaphragm having an instrument orifice. The instrument orifice may be expandable. The diaphragm may be disposed in the delivery lumen. The diaphragm may be positioned in the access opening.
  • The elongated member includes a needle.
  • The outer surface may have, in a distal region, a distal diameter; and, in a proximal region, a proximal diameter that is greater than the distal diameter.
  • The elongated member may include a catheter. The catheter may have an inside diameter in the range of about 0.1 to about 3 millimeter (“mm”); and an outside diameter in the range of about 1 to about 4 mm. The inside diameter may have any suitable length. The outside diameter may have any suitable length.
  • The catheter may be part of a delivery system for delivering a prosthetic valve into the heart. When the catheter is part of the delivery system, the prosthetic valve may be crimped onto a distal tip of the catheter. The catheter, with the valve, may be inserted into the access opening. The outer surface of the catheter may be in contact with the heart wall. The contact may be direct contact. The catheter, with the valve, may be inserted through the access opening within a sheath. The sheath may maintain the valve in an unexpanded state until the valve is in position for deployment. The sheath may be withdrawn proximally to allow a distal end of the valve to expand and engage heart anatomy. Further withdrawal of the sheath may allow a proximal end of the valve to expand and engage heart anatomy.
  • The catheter, with the valve, may be inserted through an introducer. The introducer may have an outer surface that is in contact with the heart wall. The contact may be direct contact.
  • The catheter may be any suitable size, including about 33Fr to about 24Fr and any suitable sizes below, within or above that range.
  • The elongated member may include an introducer. The introducer may have an inside diameter in the range of about 0.1 to about 18 mm; and an outside diameter in the range of about 5 to about 20 mm. The inside diameter may have any suitable length. The outside diameter may have any suitable length.
  • A portion of the elongated member may be in a contracted state. The contracted state may be a mechanical equilibrium state. When the portion of the elongated member is in the contracted state, a corresponding portion of the electrically conductive member may be disposed at a first radial distance from a longitudinal central axis of the delivery lumen. The portion of the elongated member may be changed to an expanded state. When the portion of the elongated member is in the expanded state, the corresponding portion of the electrically conductive member may be disposed at a second radial distance from the axis. The second radial distance may be greater than the first radial distance.
  • The portion of the electronically conductive member may be a first portion of the electronically conductive member. When the portion of the elongated member is in the expanded state, a second portion of the electrically conductive member, which may be disposed longitudinally away from the first portion, may be disposed at the first radial distance from the axis.
  • The elongated member may include material that is configured to deform radially in response to displacement through the delivery lumen of an instrument having an outer diameter that is greater than an inner diameter of the lumen.
  • The material may be configured to elastically relax after passage of the instrument. Relaxation of the material may return the first portion of the electrically conductive member substantially to the first radial distance.
  • The material is configured so that the inner diameter remains deformed substantially commensurate with the outer diameter of the instrument after passage of the instrument.
  • The instrument that displaces the elongated member may be a blunt rod. The instrument that displaces the elongated member may be a therapeutic device. The instrument that displaces the elongated member may be a prosthetic heart valve or any other suitable therapeutic device such as one or more of the devices described or shown herein.
  • Apparatus and methods for plugging the access opening are provided. The apparatus may include a body. The body may include a distal end. The distal end may be configured to be disposed interior the heart. The distal end may be configured to contact endocardial tissue adjacent the access opening. The apparatus may include a proximal end. The proximal end may be configured to be disposed exterior the heart. The proximal end may be configured to contact pericardial tissue adjacent the access opening. The apparatus may include an electrode. The electrode may be supported by the body. The electrode may be configured to discharge electrical energy into the heart wall to change a frequency of contraction of the heart. The apparatus may include any suitable number of electrodes.
  • The plug may include, for each electrode, a current supply lead. The current supply lead may receive one or more cardiac pacing signals from a cardiac pacing signal generator. A connector may be provided for placing the current supply lead in electrical communication with the cardiac pacing signal generator. The cardiac pacing signal generator may include any suitable pacing device.
  • The body may include a stem that extends between the distal end and the proximal end. The body may include a shaft that extends between the distal end and the proximal end. The shaft may have one or more features in common with the stem. The stem may have a first diameter. The distal end may have a second diameter. The second diameter may be greater than the first diameter. The proximal end may have a third diameter. The third diameter may be greater than the first diameter.
  • The electrode may discharge from the distal end. The electrode may discharge from the proximal end. The electrode may discharge from the stem. The electrode may discharge from the shaft.
  • The body may include a second electrode. The second electrode may be configured to discharge electrical energy into the heart wall to change the frequency of contraction of the heart.
  • The body may include a sensor for sensing a native cardiac electric field.
  • The body may include, in the distal end, a sensor for sensing a blood pressure inside the heart.
  • The body may include a sensor for measuring chemical values inside the heart. The sensor may be disposed in the distal end. The sensor may be disposed on the stem. The sensor may be disposed on the shaft. The chemical sensor may be supported by the elongated member. The chemical sensor may be supported by the electrically conductive member. The chemical sensor may be configured to measure chemical values such as, for example, pH, lactate, cardiac enzymes, electrolytes.
  • The chemical sensor may be calibrated to sense a chemical species. The species may be present in a chamber interior the heart wall. The species may be present at a myocardial tissue surface that is exposed in a heart wall access opening.
  • The chemical sensor may detect the chemical value based on conductivity of the heart wall. The chemical sensor may detect the chemical value based on capacitance of the heart wall. The chemical sensor may detect the chemical value based on an electrical potential of the heart wall. The chemical sensor may include a porous layer. The chemical sensor may detect the chemical value based on conductivity of the porous layer. The chemical sensor may detect the chemical value based on capacitance of the porous layer. The chemical sensor may detect the chemical value based on an electrical potential of the porous layer.
  • The sensor may transmit a chemical value signal based on the chemical value to a processor outside the heart. The sensor may transmit the chemical value sensor by wire. The sensor may transmit the chemical value sensor wirelessly.
  • The body may include an electrical energy storage source such as a battery. The body may include a pacing signal generator. The battery may supply electrical current to the electrodes. The signal generator may control the current so that the current is provided in a therapeutic form.
  • The battery may be separate from the body. The battery may be separately implantable in the patient and in wired electrical communication with the body.
  • The battery may be inductively recharged from a source exterior the patient.
  • The apparatus may include a processor that is configured to change a pacing parameter, for example, a frequency of the current based on the native cardiac signal. The processor may be configured to change the pacing parameter based on one or more pressure signal. The processor may be configured to change the pacing parameter based on one or more chemical signal.
  • The methods may include inserting an elongated member through an access opening in the heart. The methods may include transferring electrical energy from the elongated member to the heart to change a frequency of contractions of the heart. The methods may include delivering an instrument through the elongated member.
  • The transferring may include discharging the electrical energy across a contact interface between the elongated member and the heart.
  • The method may include sensing an electric field of the heart at the elongated member. The method may include changing the contraction frequency based on the electric field.
  • The method may include sensing a blood pressure in the heart at the elongated member. The method may include changing the frequency based on the pressure.
  • The method may include sensing a chemical value in the heart at the elongated member. The method may include changing the contraction frequency based on the chemical value.
  • The method may include preventing blood loss through the access opening by maintaining the elongated member in the access opening.
  • The delivering may include delivering a guide wire.
  • The delivering may include delivering a catheter.
  • The delivering may include delivering an introducer. The delivering may include delivering a introducer. The introducer may include a hemostatic valve.
  • The delivering may include delivering an ultrasound receiver.
  • The delivering may include delivering an embolic protection device.
  • The delivering may include delivering a valve resection device. The resection device may be used to resect a heart valve. The resection device may be used to treat a hypertrophic obstruction. The resection device may be used to treat a subvalvular obstruction.
  • The delivering may include delivering a prosthetic valve. The valve may be a stent valve. The stent valve may be self-expanding. The stent valve may be balloon-expandable.
  • The method may include deploying from the elongated member an access opening plug.
  • The method may include transferring electrical energy from the plug to the heart to change the frequency of contractions of the contractions.
  • The method may include displaying a live image of the elongated member as positioned inside the access opening. The method may include displaying, adjacent the live image, a native cardiac electric field trace. The method may include displaying, adjacent the live image, an internal cardiac blood pressure trace.
  • Apparatus for pacing a heart with an injectable needle are provided. The apparatus may include a sharp end that is configured to pierce tissue; a base opposite the sharp end, the base being configured to receive an impulse to drive the sharp end into the tissue; an elongated member bearing an electrode, the elongated member extending from the sharp end to the base; and an electrically conducting lead that is connected to the electrode and is configured to receive current for delivery to the heart through the electrode when the electrode is embedded in the heart.
  • The electrode may be elongated along a longitudinal direction of the elongated member.
  • When the electrode is a first electrode and the electrically conducting lead is a first electrically conducting lead, the apparatus may include a second electrode that is borne by the elongated member; and a second electrically conducting lead that is connected to the electrode and is configured to receive current for delivery to the heart through the second electrode when the second electrode is embedded in the heart.
  • The base may be configured to receive the impulse from a firing peg, a spring, a pressurized gas, or any other suitable impulse source.
  • The base may include a magnet. When the base includes a magnet, the base may be configured to receive the impulse from a magnetic field. The magnetic field may be provided by a coil.
  • Apparatus and methods in accordance with the invention will now be described in connection with the Figures. The features are illustrated in the context of selected embodiments. It will be understood that features shown in connection with one of the embodiments may be practiced in accordance with the principles of the invention along with features shown in connection with others of the embodiments.
  • Apparatus and methods described herein are illustrative. Apparatus and methods of the invention may involve some or all of the features of the illustrative apparatus and/or some or all of the steps of the illustrative methods. The steps of the methods may be performed in an order other than the order shown and described herein. Some embodiments may omit steps shown and described in connection with the illustrative methods. Some embodiments may include steps that are not shown and described in connection with the illustrative methods.
  • The apparatus and methods of the invention will be described in connection with embodiments and features of illustrative heart treatment devices and associated hardware and instrumentation. The device and associated hardware and instruments will be described now with reference to the FIGS. It is to be understood that other embodiments may be utilized and structural, functional and procedural modifications may be made without departing from the scope and spirit of the present invention.
  • FIG. 1 schematically shows illustrative instrument 100 for performing a procedure on a heart such as heart H. The procedure may be performed on anatomy in or about heart H. The procedure may be performed on anatomy in or about a chamber of heart H such as chamber Hc. Chamber Hc may be a left ventricle, a right ventricle, a left atrium or a right atrium. The procedure may be performed on vasculature in or about heart H or on any other structure in or about heart H. Heart H may contract at a frequency.
  • Heart H may include pericardium Hp, myocardium Hm and endocardium He. Heart H may include apex Ha. Heart H may include heart wall H. Heart wall Hw may include one or more of pericardium Hp, myocardium Hm and endocardium He. Heart wall Hw may include a septum between two cardiac atria. Heart wall Hw may include a septum between two cardiac ventricles.
  • Instrument 100 may include elongated member 102. Elongated member 102 may be cannulated. Elongated member 102 may include outer surface 104. Outer surface 104 may resist closure of access opening Ho in heart wall H. The pressure of heart wall Hw on outer surface 104 may be sufficient to prevent the leakage of blood Hb from interior H, of chamber H, between outer surface 104 and heart wall Hw to exterior Hext of heart H. The pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 104 and heart wall H.
  • Instrument 100 may include one or more electrically conductive members such as representative electrically conductive member 106. One or more of electrically conductive members 106 may be supported by elongated member 102. One or more of electrically conductive members 106 may be supported by outer surface 104. One or more of electrically conductive members 106 may be used to provide electrical pulses to heart wall Hw to change the contraction frequency. One or more of electrically conductive members 106 may be placed in direct contact with heart wall Hw to provide the electrical pulses. The energy may be supplied via a cable such as 108 from source 110. The energy may be supplied wirelessly from source 110. Source 110 may be programmable via control panel 112. Source 110 may be incorporated into instrument 100. Source 110 may be or include a pacing device.
  • One or more additional electrically conductive members may have a distal end that is placed in electrical communication with epidermal tissue on the body in which the heart is disposed. The one or more additional electrically conductive members may have a proximal end that is in electrical communication with control panel 112.
  • Instrument 100 may be displaced along longitudinal axis L. Instrument 100 may be rotated in circumferential direction θ. Instrument 100 may be radially tapered, along axis L, with respect to radial direction R. Instrument 100 may deliver the pulses while instrument 100 is moving longitudinally. Instrument 100 may deliver the pulses while instrument 100 is rotating.
  • One or more of electrically conductive members 106 may remain in direct contact with heart wall Hw while instrument 100 is moving longitudinally. One or more of electrically conductive members 106 may remain in direct contact with heart wall Hw while instrument 100 is rotating. One or more of electrically conductive members 106 may have a length Le. Access opening Ho may have a thickness to. Length Le may be greater than thickness to such that instrument 100 may move longitudinally without removing the electrically conductive member from contact with heart wall H.
  • One or more of electrically conductive members 106 may sense a native cardiac electric field. A signal corresponding to the field may be transmitted to source 110. The signal may be transmitted via cable 108. The signal may be transmitted wirelessly. Instrument 100 may include one or more electrically conductive members 106 that are wired to provide pulses to heart wall Hw and one or more electrically conductive members 106 that are wired to transmit a native cardiac electric field signal to an electrocardiograph device.
  • Instrument 100 may include one or more antennae such as representative antenna 114. Antennae 114 may sense a native cardiac electric field. A signal corresponding to the field may be transmitted to source 110. The signal may be transmitted via cable 108. The signal may be transmitted wirelessly.
  • Instrument 100 may include one or more pressure sensors such as representative pressure sensor 116. Pressure sensor 116 may sense a pressure of blood Hb. A signal corresponding to the pressure may be transmitted to source 110. The signal may be transmitted via cable 108. The signal may be transmitted wirelessly.
  • Instrument 100 may include one or more pressure sensors such as representative pressure sensor 119. Pressure sensor 119 may have one or more features in common with pressure sensor 116. Pressure sensor 119 may be one of an array of pressure sensors. Pressure sensor 119 may sense the pressure of heart wall Hw against outer surface 104 in access opening Ho. Each of the pressure sensors in the array may be monitored individually so that a reading may be taken from one or more of the pressure sensors that is in access opening Ho. When elongated member 102 is in different longitudinal positions relative to heart wall Hw, it may be necessary or desirable to monitor the pressure sensed by a sensor that is inside access opening Ho and not in chamber Hc or in the exterior Hext of the heart. In this way, the pressure in access opening Hc can be monitored while elongated member 102 is in different positions or is in motion.
  • Instrument 100 may include one or more chemical sensors such as representative chemical sensor 117. A signal corresponding to the concentration of a chemical may be transmitted to source 110. The signal may be transmitted via cable 108. The signal may be transmitted wirelessly.
  • Instrument 100 may include one or more chemical sensors such as representative chemical sensor 107. Chemical sensor 107 may have one or more features in common with chemical sensor 117. Chemical sensor 107 may be one of an array of chemical sensors. Chemical sensor 107 may sense the presence at an exposed surface of heart wall Hw in access opening Ho of a chemical compound or species. Each of the chemical sensors in the array may be monitored individually so that a reading may be taken from one or more of the chemical sensors that is in access opening Ho. When elongated member 102 is in different longitudinal positions relative to heart wall Hw, it may be necessary or desirable to monitor the chemical value sensed by a sensor that is inside access opening Ho and not in chamber Hc or in the exterior Hext of the heart. In this way, the chemical value in access opening Hc can be monitored while elongated member 102 is in different positions or is in motion.
  • One or more of the pressure sensors and chemical sensors may have a length Ls. Length Ls may be lesser than thickness to such that when instrument 100 moves longitudinally through heart wall Hw, one of the pressure sensors or chemical sensors will sense, respectively, a pressure or chemical signal that is representative of heart wall Hw. For example, Ls may be in the range of about to to to/2, to/2 to about to/4, about to/4 to to/8 or smaller.
  • The pulses may be defined by parameters such as energy, duration, frequency, voltage, current and any other suitable parameters. The parameters may be selected manually via control panel 112. Source 110 may include one or more control algoritHms for setting one or more parameters of the pulses. The algoritHms may be selected via control panel 112. The algoritHms may include settings that may be adjusted via control panel 112.
  • Instrument 100 may be used to deploy another instrument such as catheter C, guidewire W or any other instrument. One or more of the elements of instrument 100 may be embodied in a needle, a catheter, an introducer or any other instrument that may be involved in the procedure.
  • When instrument 100 is an introducer, it may be used together with obliterator 101. Obliterator 101 may be a cannulated element that nests coaxially inside instrument 101. Obliterator 101 may include taper 103. Taper 103 may be extended distally of instrument 101 to present taper 103 to access hole Ho when access hole Ho is too small to accept the diameter of instrument 101. Taper 103 may be used to open access hole Ho to accept instrument 101. Obliterator 101 may then be withdrawn proximally from instrument 100 to enable instrumentation to pass through the inside diameter of instrument 100.
  • Source 110 may be communication, for example, via cable 118, or wirelessly, with other clinical signals. For example, source 110 may exchange information with a medical imaging system (not shown). The medical imaging system may provide an image of instrument 100 during the procedure. The image may be a fluoroscopic image or any other suitable image. Source 110 may provide information such as the native cardiac field, the pressure or any other suitable information. The image and the information may be displayed together on display 120. Display 120 may be collocated with instrument 100, for example, in the same operating theater. Display 120 may be located remotely from instrument 100, for example, at a distant location for observation by a distant practitioner. For example, display 120 may display image 122, electric field trace 124, pressure trace 126 or any other suitable trace. The image and the traces may be live and may be combined into an integrated image signal before being displayed by display 120.
  • FIG. 2 shows a view taken along lines 2-2 (shown in FIG. 1). FIG. 2 shows elongated member 102 in access opening Ho. In region 200, outer surface 104 is in direct contact with myocardium Hm. In region 202, one of electrically conductive members 106 is in direct contact with myocardium Hm. In region 204, one of electrically conductive members 106 is in indirect contact with myocardium Hm. In region 204, fluid F intervenes between the electrically conductive member and myocardium Hm. Fluid F may include blood, such as blood Hb. Fluid F may include an irrigation fluid, such as water or saline solution. Fluid F may include any other suitable fluid.
  • In regions 204 and 206, one of electrically conductive members 106 is in indirect contact with myocardium Hm. In region 206, fluid F and gas G intervene between the electrically conductive member and myocardium Hm. Gas G may include air.
  • FIGS. 3-10 show illustrative steps of a procedure that may involve apparatus having features such as those illustrated in connection with instrument 100 (shown in FIG. 1).
  • FIG. 3 schematically shows illustrative access needle 300 penetrating heart wall Hw of heart H. Needle 300 may include elongated member 302. Elongated member 302 may include tissue-piercing tip 303. Elongated member 302 may include outer surface 304. Outer surface 304 may resist closure of access opening Ho in heart wall H. The pressure of heart wall Hw on outer surface 304 may be sufficient to prevent the leakage of blood Hb from interior Hi of chamber Hc between outer surface 304 and heart wall Hw to exterior Hext of heart H. The pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 304 and heart wall H.
  • Needle 300 may include one or more electrically conductive members such as representative electrically conductive member 306. One or more of electrically conductive members 306 may be supported by elongated member 302. One or more of electrically conductive members 306 may be supported by outer surface 304. One or more of electrically conductive members 306 may be used to provide electrical pulses to heart wall Hw to change the contraction frequency.
  • Needle 300 may include an delivery lumen (not shown). The delivery lumen may be used to deliver an instrument to interior Hi. The instrument may be any suitable instrument, such as guidewire G.
  • FIG. 4 shows needle 300 advanced longitudinally through heart wall Hw. Electrically conductive members 306 remain in contact with heart wall Hw.
  • FIG. 5 shows wire W advanced longitudinally through needle 300. Wire W passes through aortic valve HAV into arterial vasculature (not shown). A distal end (not shown) of wire W may be captured by instrumentation (not shown) in the arterial vasculature. Wire W may be advanced through mitral valve Hmv. Electrically conductive members 306 remain in contact with heart wall Hw.
  • FIG. 6 schematically shows illustrative catheter 600 in access opening Ho. Catheter 600 may have replaced needle 300 (shown in FIG. 3). Wire W may have been left in place upon the removal of needle 300. Catheter 600 may have been guided into chamber Hc along wire W. Catheter 600 may include elongated member 602. Elongated member 602 may include outer surface 604. Outer surface 604 may resist closure of access opening Ho in heart wall Hw. The pressure of heart wall Hw on outer surface 604 may be sufficient to prevent the leakage of blood Hb from interior Hi of chamber Hc between outer surface 604 and heart wall Hw to exterior Hext of heart H. The pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 604 and heart wall Hw.
  • Catheter 600 may include one or more electrically conductive members such as representative electrically conductive member 606. One or more of electrically conductive members 606 may be supported by elongated member 602. One or more of electrically conductive members 606 may be supported by outer surface 604. One or more of electrically conductive members 606 may be used to provide electrical pulses to heart wall Hw to change the contraction frequency.
  • FIG. 7 shows wire catheter 600 (shown in FIG. 6) advanced longitudinally through access opening Ho. Catheter 600 passes through aortic valve HAV into arterial vasculature (not shown). Electrically conductive members 606 remain in contact with heart wall Hw.
  • FIG. 8 schematically shows illustrative introducer 800 in access opening Ho. Introducer 800 may have been coaxially placed on catheter 600. Catheter 600 may be used to guide introducer 800 into place in access opening Ho. Introducer 800 may include elongated member 802. Elongated member 802 may include outer surface 804. Outer surface 804 may resist closure of access opening Ho in heart wall H. The pressure of heart wall Hw on outer surface 804 may be sufficient to prevent the leakage of blood Hb from interior Hi of chamber Hc between outer surface 804 and heart wall Hw to exterior Hext of heart H. The pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 804 and heart wall Hw.
  • Introducer 800 may include one or more electrically conductive members such as representative electrically conductive member 806. One or more of electrically conductive members 806 may be supported by elongated member 802. One or more of electrically conductive members 806 may be supported by outer surface 804. One or more of electrically conductive members 806 may be used to provide electrical pulses to heart wall Hw to change the contraction frequency. One or more of electrically conductive members 806 may be placed in direct contact with heart wall Hw to provide the electrical pulses.
  • Introducer 800 may advance and withdraw longitudinally through access opening Ho. Electrically conductive members 806 remain in contact with heart wall Hw.
  • Introducer 800 may include valve 808. Valve 808 may include an orifice that deforms around an instrument that passes through introducer 800. The instrument may thus be passed through valve 808 while valve 808 reduces or eliminates the loss of blood Hb through introducer 800.
  • Introducer 800 may be used in conjunction with obliterator 810. Obliterator 810 may have one or more features in common with obliterator 101.
  • FIG. 9 shows introducer 800 in opening Ho after withdrawal of catheter 600. One, both or neither of balloons 900 and 902 may be present adjacent distal and proximal contacts, 904 and 906, respectively, between outer surface 804 and heart wall H. The balloons may interfere with the leakage of blood from heart H.
  • FIG. 10 shows prosthetic valve V, which has been delivered through introducer 800 and positioned in aortic valve annulus HA. Annulus HA may have resulted from the resection of aortic valve HAV (shown in FIG. 9). The resection may have been performed by deploying resection tools through introducer 800. Valve V may be delivered at the distal tip of a catheter (not shown) such as 600 (shown in FIG. 6).
  • Valve V may be delivered at the distal tip of the catheter in a procedure that does not involve introducer 800. For example, valve V may fixed to the tip of catheter 600 and advanced distally as catheter 600 is advanced as shown in FIGS. 6 and 7.
  • FIG. 10 shows valve delivery catheter 1000 extending through introducer 800, although valve delivery catheter 1000 may have one or more features in common with catheter 600 and may be used without an introducer. Catheter 1000 may be advanced and withdrawn through access opening 600 to first deploy proximal fitting 1002 of heart valve V, then stretch distal end 1004 of heart valve V distal of coronary sinuses HcS and secure distal end 1004 to aortic wall HAW. This may properly configure commissure support tissue 1006 to function. Balloon 1008 may be used to radially expand base ring 1010 of valve V. When valve V is deployed without the use of introducer 800, electrically conductive members 606 (shown in FIG. 6) may provide pulses to heart wall Hw while catheter 600 is advanced and withdrawn in connection with the deployment of valve V and the withdrawal from heart wall Hw of catheter 600.
  • FIG. 11 shows valve V in place in aortic rim HAR. Introducer 800 and wire W have been withdrawn from heart wall Hw. Electrically conductive members 806 may have provided pulses to heart wall Hw during withdrawal of introducer 800 from heart wall Hw. Closure device 1100 may be deployed in access opening Ho. Closure device 1100 may provide a seal for access opening Ho and may prevent blood Hb from exiting access opening Ho. The seal may be a temporary seal. The seal may be a permanent seal. Closure device 1100 may be deployed through introducer 800. Closure device 1100 may be deployed without the use of introducer 800.
  • Closure device 1100 may include distal end 1102. Closure device may include stem 1104. Closure device may include proximal end 1106. Closure device may include one or more electrically conductive members, such as 1108, 1110, 1112 and 1114.
  • Leads such as 1120, 1122, 1124 and 1126 may provide the electrically conductive members with electrical pulses for conduction to the heart.
  • FIG. 12 shows, in a view similar to that which would be seen along lines 12-12 (shown in FIG. 1), an illustrative partial cross-section of instrument 1200. Instrument 1200 may have one or more features in common with instrument 100, needle 300, catheter 600 or introducer 800.
  • Instrument 1200 may include elongated member 1202. Elongated member 1202 may include outer surface 1204.
  • Instrument 1200 may include one or more electrically conductive members such as representative electrically conductive member 1206. One or more of electrically conductive members 1206 may be used to provide electrical pulses to heart wall Hw to change the contraction frequency. One or more of electrically conductive members 1206 may be placed in direct contact with heart wall Hw to provide the electrical pulses. The energy may be supplied by leads such as 1208 from a source such as 110 (shown in FIG. 1). The energy may be supplied wirelessly from the source 110.
  • Electrically insulating members 1210 may electrically insulate electrically conducting members 1206 from elongated member 1202. When elongated member 1202 is an electrical insulator, electrically insulating members 1210 may not be included.
  • Instrument 1200 may include delivery lumen 1212 for delivering an instrument to the heart.
  • FIG. 13 shows, along lines 13-13 (shown in FIG. 12), a cross-section of instrument 1200. Electrically conductive members 1206 and electrically insulating members 1210 may be flush with outer surface 1204 of elongated member 1202.
  • FIG. 14 shows, in a view similar to that along lines 14-14 (shown in FIG. 12), a cross-section of instrument 1400, which may have one or more features in common with instrument 1200. Instrument 1400 may include elongated member 1402. Elongated member 1402 may include outer surface 1404. Instrument 1400 may include electrically conductive members 1406 and electrically insulating members 1410. Electrically conductive members 1406 may extend radially away from outer surface 1404. Electrically insulating members 1410 may be flush with outer surface 1404. When elongated member 1402 is an electrical insulator, electrically insulating members 1410 may not be included.
  • Instrument 1400 may include delivery lumen 1412 for delivering an instrument to the heart.
  • FIG. 15 shows, in a view similar to that which would be seen along lines 15-15 (shown in FIG. 1), an illustrative partial cross-section of instrument 1500. Instrument 1500 may have one or more features in common with instrument 100, needle 300, catheter 600, introducer 800, instrument 1200 or instrument 1300.
  • Instrument 1500 may include elongated member 1502. Elongated member 1502 may include outer surface 1504.
  • Instrument 1500 may include one or more electrically conductive members such as representative electrically conductive member 1506. One or more of electrically conductive members 1506 may be used to provide electrical pulses to heart wall Hw to change the contraction frequency. One or more of electrically conductive members 1506 may be placed in direct contact with heart wall Hw to provide the electrical pulses. The energy may be supplied by leads such as 1508 from a source such as 110 (shown in FIG. 1). The energy may be supplied wirelessly from the source 110.
  • Electrically insulating members 1510 may electrically insulate electrically conducting members 1506 from elongated member 1502. When elongated member 1502 is an electrical insulator, electrically insulating members 1510 may not be included.
  • One or more of electrically conducting members 1506 and electrically insulating members 1510 may include tape. One or more of electrically conducting members 1506 and electrically insulating members 1510 may include a thin film. The thin film may be deposited on outer surface 1504. The thin film may deposited on electrically insulating members 1510. The thin film may be printed lithographically.
  • Instrument 1500 may include delivery lumen 1512 for delivering an instrument to the heart.
  • FIG. 16 shows, along lines 16-16 (shown in FIG. 15), a cross-section of instrument 1500.
  • FIG. 17 shows illustrative instrument 1700. Illustrative instrument 1700 may have one or more features in common with instrument 100, needle 300, catheter 600, introducer 800, instrument 1200, instrument 1300 or instrument 1500.
  • Instrument 1700 may include elongated member 1702. Elongated member 1702 may include outer surface 1704. Outer surface 1704 may resist closure of access opening Ho in heart wall Hw. The pressure of heart wall Hw on outer surface 1704 may be sufficient to prevent the leakage of blood Hb from interior Hi of chamber Hext between outer surface 1704 and heart wall Hw to exterior Hext of heart H. The pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 1704 and heart wall Hw.
  • Instrument 1700 may include one or more electrically conductive members such as representative electrically conducting member 1706. One or more of electrically conductive members 1706 may be used to provide electrical pulses to heart wall Hw to change the contraction frequency. One or more of electrically conductive members 1706 may be placed in direct contact with heart wall Hw to provide the electrical pulses. The energy may be supplied via a cables such as 1708.
  • Instrument 1700 may include an instrument delivery lumen (not shown). Instrument 1700 may include instrument introduction port 1712. Instrument 1700 may include fluid exchange port 1714.
  • FIG. 18 is a view of region 18 of instrument 1700 (shown in FIG. 17).
  • FIG. 19 shows illustrative electrically conductive member 1900 being deployed in myocardium Hm of heart H. Electrically conductive member 1900 may be permanently deployed in myocardium Hm. Electrically conductive member 1900 may be temporarily deployed in myocardium Hm.
  • Electrically conductive member 1900 may be deployed via deployment lumen 1902 in elongated member 1904. Elongated member 1904 may be part of an instrument such as instrument 100, needle 300, catheter 600, introducer 800, instrument 1200, instrument 1300, instrument 1500, instrument 1700 or instrument 1900.
  • Elongated member 1904 may positioned by displacing flexible control link 1908 longitudinally along deployment lumen 1902. Flexible control link 1908 may be detachable from electrically conductive member 1900 to deploy electrically conductive member 1900 in heart H. Conductor 1910 may supply the pulses to electrically conductive member 1900. Conductor 1910 may remain attached to electrically conductive member 1900 after control link 1908 is detached from electrically conductive member 1900.
  • Flexible control link 1908 may be detachably attached to electrically conductive member 1900 via any suitable mechanism such as a key, threaded union, an interference fit, a snap fit, a snap fit with a spring-biased tang or any other suitable mechanism.
  • Electrically conductive member 1900 may include one or more anchoring mechanisms such as representative flexible barb 1914 or any other suitable anchoring mechanism or substance. For example, the anchoring system may include a spiral thread, circumferential ribs, epoxy, adhesive or any other suitable anchoring mechanism or substance.
  • FIG. 20 shows illustrative control catheter 2002. Flexible control link 1908 may run through control catheter 2002. Control catheter 2002 may include distal end 2004 that abuts or engages base 2006 of electrically conductive member 1900. Distal end 2004 may provide force to the base so that electrically conductive member 1900 can resist forces associated with the disengagement of flexible control link 1908 from electrically conductive member 1900.
  • Control link 1908 may engage and disengage electrically conductive member 1900 via “T”-key 2008 in slot 2010. Slot 2012 in electrically conductive member 1900 may be keyed to accommodate passage of “T”-key 2008.
  • FIG. 21 schematically shows illustrative introducer 2100 in access opening Ho. Introducer 2100 may have one or more features in common with instrument 100, needle 300, catheter 600, introducer 800, instrument 1200, instrument 1300, instrument 1500 or instrument 1700.
  • Introducer 2100 may have been coaxially placed on catheter 600. Catheter 600 may be used to guide introducer 2100 into place in access opening Ho. Introducer 2100 may include elongated member 2102. Elongated member 2102 may include outer surface 2104. Outer surface 2104 may resist closure of access opening Ho in heart wall Hw. The pressure of heart wall Hw on outer surface 2104 may be sufficient to prevent the leakage of blood Hb from interior Hi of chamber Hc between outer surface 2104 and heart wall Hw to exterior Hext of heart H. The pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 2104 and heart wall Hw.
  • Introducer 2100 may include one or more electrically conductive members such as representative electrically conductive member 2106. One or more of electrically conductive members 2106 may be supported by elongated member 2102. One or more of electrically conductive members 2106 may be supported by outer surface 2104. One or more of electrically conductive members 2106 may be used to provide electrical pulses to heart wall Hw to change the contraction frequency. One or more of electrically conductive members 2106 may be placed in direct contact with heart wall Hw to provide the electrical pulses.
  • Introducer 2100 may advance and withdraw longitudinally through access opening Ho. Electrically conductive members 2106 remain in contact with heart wall Hw.
  • Introducer 2100 may include valve 2108. Valve 2108 may include an orifice that deforms around an instrument that passes through introducer 2100. The instrument may thus be passed through valve 2108 while valve 2108 reduces or eliminates the loss of blood Hb through introducer 2100.
  • Introducer 2100 may be used in conjunction with obliterator 2110. Obliterator 2110 may have one or more features in common with obliterator 101 or obliterator 810.
  • Illustrative injection catheter 2110 may be provided coaxially about instrument 2100. Injection catheter 2110 may be configured to insert electrically conductive members in heart H. Injection catheter 2110 may be configured to be provided coaxially about one or more of instrument 100, needle 300, catheter 600, introducer 800, instrument 1200, instrument 1300, instrument 1500 and instrument 1700.
  • FIG. 22 shows in part a partial cross-sectional view of injection catheter 2110 about introducer 2100. Injection catheter 2210 may include distal end 2212. Distal end 2212 may be contoured to conform or partially conform to pericardium Hp. Injection catheter may include one or more deployment lumens such as representative deployment lumen 2214. Electrically conducting members such as representative electrically conducting member 2216 may be inserted in myocardium Hm using deployment lumens such as representative deployment lumen 2214. Electrically conducting member 2216 may have one or more feature in common with electrically conducting member 2000 (shown in FIG. 20). Injection catheter 2210 may include one or more flexible control link such as representative control link 2218. Flexible control link 2218 may have one or more features in common with flexible control link 2008. Injection catheter 2210 may include one or more conductors such as representative conductor 2220. Conductor 2220 may have one or more features in common with conductor 2010.
  • FIG. 23 schematically shows illustrative access opening closure device 2300. Closure device 2300 may have one or more features in common with closure device 1100 (shown in FIG. 11). Closure device 2300 may be inserted in access opening Ho. Closure device 2300 may include distal end 2302, stem 2304 and proximal end 2306. One or both of distal end 2302 and proximal end 2306 may have a shape, such as a disc, a cone or a dome to rest flush against endocardium He or pericardicum Hp. The shape reduce or prevent the leakage of blood Hb from heart interior Hi. One or more of distal end 2302, stem 2304 and proximal end 2306 may include elastic material. The elastic material may allow stem 2302 to be set in tension across heart wall Hw. The tension may compress distal edge 2308 against endocardium He.
  • Closure device 2300 may be deployed in access opening Ho by delivering distal end 2302 through a cannulated instrument, such as instrument 100 (shown in FIG. 1), when it is cannulated, through access opening Ho to heart interior Hi. While retaining proximal end 2306, the distal tip of instrument 100 may be withdrawn from access opening Ho and proximal end 2306 may be released in the heart exterior region Hext. Tension in closure device 2300 may then urge proximal end 2306 into position against heart H. Pericardium Hp may be retracted so that proximal end 2306 is in contact with myocardium Hm.
  • Closure device 2300 may include body 2310. Body 2310 may include some or all of distal end 2302, stem 2304 and proximal end 2306. Body 2310 may include electrically insulating material such as a polymer that is less electrically conductive than metal or electrically conductive polymer.
  • Distal end 2302 may include one or more electrically conductive members such as representative conductive member 2312. Electrically conductive member 2312 may extend around the circumference of distal end 2302. Proximal end 2302 may include one or more electrically conductive members such as representative electrically conductive member 2314. Electrically conductive member 2314 may extend around the circumference of distal end 2302.
  • Stem 2302 may include one or more electrically conductive members such as representative conductive member 2316. The elastic material may allow stem 2302 to be set in radial compression against heart wall H. The compression may maintain electrically conductive member 2316 in contact with heart wall H. Electrically conductive member 2316 may have one or more features in common with electrically conductive member 106 of instrument 100 (shown in FIG. 1).
  • FIG. 24 shows a cross sectional view of closure device 2300 taken along lines 24-24 (shown in FIG. 23). Electrically conductive members 2312 and 2314 may be in electrical communication with a source such as source 110 (shown in FIG. 1) via conductors 2416 and 2418. Electrically conductive member 2316 may be in electrical communication with a source such as source 110 (shown in FIG. 1) via conductor 2422. The conductors may lead out of closure device 2300 via ported seal 2420. The conductors may run in space 2424, which may be a lumen.
  • FIG. 25 shows a cross-sectional view of closure device 2300 taken along lines 25-25 (shown in FIG. 24). Electrically conductive member 2316 runs circumferentially around some or all of stem 2304. Conductor 2422 runs radially between space 2424 and electrically conductive member 2316. Conductor 2416 runs longitudinally through space 2424.
  • FIG. 26 shows in cross section illustrative proximal end 2600 of a closure device such as 2300 (shown in FIG. 23). Proximal end 2600 may have one or more features in common with proximal end 2306 (shown in FIG. 23). Proximal end 2600 may include removable cap 2602. Cap 2602 may be connected to closure device body in recess 2604. Cap 2602 may be secured in recess 2604 by any suitable mechanism such as threads (not shown), a clasp (not shown), a suture (not shown), an interference fit with rib 2606 or any other suitable mechanism.
  • Cap 2602 may include one or more terminal pins such as representative pin 2608. Terminal pin 2608 may be in electrical communication distally with a source such as 110 (shown in FIG. 1). Terminal pin 2608 may be inserted into receptacle 2610. Terminal pin 2608 may be in electrical communication with receptacle 2610. Receptacle 2610 may be in electrical communication with one or more conductors, such as conductor 2612 that lead to one or more electrically conducting members on body 2606.
  • The electrically conducting members may have one or more features in common with the electrically conducting members of closure device 2300 (shown in FIG. 23).
  • Cap 2602 may be removed from distal end 2600. For example, the closure device may be deployed in heart H after delivery of an instrument to interior Hi of heart H. The closure device may remain in heart H while a patient is under postoperative observation. Cap 2602 may be removed. The removal of cap 2602 may disconnect terminal pin 2608 from receptacle 2610. The closure device may thus be disconnected from a source such as 110 (shown in FIG. 1).
  • A replacement cap (not shown) may be installed in recess 2604. The replacement cap may have one or more non-conducting pins that mate with receptacles such as 4610. The replacement cap may seal against distal end 2600 to prevent fluids from interacting with receptacle 2610. One of the non-conducting pins may seal receptacle 2610. The replacement cap may be permanently installed in recess 2604. The replacement cap may be removably installed in recess 2604. A cap such as 2602 may be installed after removal of the replacement cap to reestablish electrical communication between one or more of the electrically conducting members and a source such as 110 (shown in FIG. 1).
  • FIG. 27 schematically shows intracardiac ultrasound receiver 2700. Intracardiac ultrasound receiver 2700 may be placed in the right atrium (not shown) via a femoral vein (not shown). Intravascular ultrasound receiver (“IVUS”) 2702 may be delivered into chamber Hc over guidewire. IVUS 2702 may be positioned in a valve such as aortic valve HAV.
  • Any suitable endovascular, endocardiac, and endoluminal visualization aids may be used. Extracorporeal X-ray-based radiographic and fluoroscopic devices may be used map and visualize anatomy and instrumentation related to the procedure.
  • IVUS 2702 may be used to locate aortic valve HAV, sino-tubular junction HSTJ, and brachio-cephalic trunk HBCT. Any suitable analytical mapping platform such as that available under the trademark ACUNAV from Biosense Webster, Inc., of Diamond Bar, Calif., may be used to track IVUS 2702 and determine the location of the anatomical features. The analytical mapping platform may be used in conjunction with fluoroscopy.
  • A radioopaque marker may be placed on the anatomical features or, in locations corresponding to the anatomical features, on the patient's skin or the heart's surface so that extracorporeal fluoroscopy can later be used to relocate the features.
  • IVUS 2702 along with the analytical mapping platform and fluoroscopy equipment may be used to take measurements of the diseased valve.
  • A camera may be inserted through the apparatus into chamber Hc. A transparent balloon (filled with a transparent fluid such as water) may be positioned in front of the camera. The camera and liquid-filled balloon are pushed against the surface that the surgeon wishes to view. The transparent balloon displaces blood from the camera's line of sight such that an image of what the camera sees through the balloon is transmitted to the surgeon.
  • One or more signals from the visualization receivers and devices may be transmitted to a display such as display 120 (shown in FIG. 1).
  • FIG. 28 shows that an instrument such as 800 (shown in FIG. 8) may deliver to the ascending aorta, near coronary sinuses ACS, illustrative embolic one or more embolic protection devices such as EPD1, EPD2 and EPD3 along guidewires W1, W2 and W3. One or more of EPD1, EPD2 and EPD3 may include a filtering mesh or net made from any suitable material. The chosen material should be able to be collapsed, expanded, and re-collapsed multiple times.
  • Embolic protection devices may be delivered through introducer 800 for placement in the brachiocephalic, left common carotid, and left subclavian arteries of the aortic arch (not shown).
  • Introducer 800 may be used to deliver a valve delivery system, such as a catheter on which is mounted an expandable valve, or a temporary valve device (not shown) to a suitable location in the vasculature. For example, when replacing the aortic valve's function, it may be preferable to place the temporary valve in the ascending aorta just distal the native aortic valve. However, it is possible to temporarily replace the aortic valve function with a device placed in the descending aorta. Such a placement may have the disadvantage of causing the heart to work harder, but such placements have been proven acceptable in previous surgical procedures.
  • Introducer 800 may be used to deliver a blood pump such as a ventricular assist device (“VAD”; not shown). The VAD or other temporary pump device may be used to support the heart's natural function while a native valve is being resected or repaired.
  • FIG. 29 shows that introducer 800 may be used to deliver balloon-actuated resection tool 2900 to heart H. Tool 2900 may include balloons 2902 and 2904. Balloons 2902 and 2904 may drive together radially expanded cutting edges 2906 and 2908 to resect a valve such as aortic valve HAV.
  • FIG. 30 shows illustrative ablation chamber 3000 that may be delivered to heart H using introducer 800. Ablation chamber 3000 is shown deployed in aorta A. Ablation chamber 3000 may include distal containment barrier 3004 and proximal containment barrier 3006. Cather C may have one or more lumens. One or more of the lumens may permit blood circulation through lumen 3007. One or more of the lumens may supply outlet 3008 with an ablation chemical. One or more of the lumens may receive ablation material from inlet 3010. A laser ablation device (not shown) may be delivered to heart H using introducer 800.
  • FIG. 31 shows illustrative fluid delivery balloon assembly 3100 that may be delivered to heart H using introducer 800. Assembly 3100 may be supported by one or both of catheter 3102 and wire 3104. Assembly 3100 may include one or more cannulated needles such as representative cannulated needle 3106. Cannulated needle 3106 may deliver a fluid to heart H. For example, the fluid may include glue. Needle 3106 may penetrate aortic dissection HAD such that a tips of needle 3106 is exposed in void Hvoid.
  • The glue may be a biologically compatible glue. The glue may be injected through needle 3106 via a glue delivery lumen (not shown) in catheter 3102. Inflation of a balloon in assembly 3100 may ensure that dissection HAD is securely affixed to aorta wall HAW by the biologically compatible glue.
  • FIG. 32 shows illustrative fluid filled bolster 3200 that may be delivered to heart H using introducer 800. Bolster 3200 may be deployed through catheter 3202. Bolster 3200 may be used to repair, stabilize or fill in left ventricular aneurysm HLVA or any other aneurysm. Bolster 3200 may be installed in aneurysm HLVA using the glue, sutures, clips or by any other suitable mounting technique.
  • FIG. 33 shows illustrative repair device 3302 that may be delivered to heart H using introducer 800. Device 3302 may be deployed through catheter 3303. Device 3302 may include one or more hooks such as 3304 and 3306. Aneurysm HLVA may be repaired by using the hooks to pull ends of aneurysm HLVA together. Hooks 3304 and 3306 may grasp the interior of heart H at extremes of aneurysm HLVA and then draw aneurysm HLVA closed. Any suitable technique can be used to secure aneurysm HLVA in the closed position (e.g., biologically compatible glue, surgical staples, mechanically placed sutures, etc.). Once the aneurysm has been sealed, repair device 3302 may be withdrawn from the patient.
  • FIG. 34 shows illustrative embolic filter 3400, temporary valve 3402 and VAD 3404 that may be delivered to heart H using introducer 800 (shown in FIG. 8). One or more of embolic filter 3400, temporary valve 3402 and VAD 3404 may be positioned using wire 3406. Wire 3406 may be delivered to heart chamber Hc using introducer 800. One or more of embolic filter 3400, temporary valve 3402 and VAD 3404 may be positioned distal aortic valve HAV in in ascending aorta HAA. Embolic filter 3400 may be configured to protect coronary arteries HCA.
  • FIG. 35 shows illustrative endoprosthesis 3500 that may be delivered to heart H using introducer 800 (shown in FIG. 8). Endoprosthesis 3500 is illustrated as being configured for deployment in aortic arch Harch, but endoprothesis 3500 may be configured to treat many different anatomical structure. Endoprosthesis 3500 may include arms such as 3502 that extend into the brachiocephalic artery, left common carotid artery, and left subclavian artery 408. Endoprosthesis 3500 may be placed using a guidewire that may pass through introducer 800 and engage a hole such as 3504. In order to aid the insertion of the arms into the arterial branches, small catheters, or other pushing devices, may be delivered through introducer 800 and inserted over guidewires to push the arms. Endoprosthesis 3500 and arm 3502 may be radially expanded once endoprosthesis 3500 is properly positioned.
  • FIG. 36 shows a cross section of illustrative needle assembly 3600. Needle assembly 3600 may include needle 3601. Illustrative needle 3601 may have one or more features in common with instrument 100, needle 300, catheter 600, introducer 800, instrument 1200, instrument 1300, instrument 1500 or instrument 1700.
  • Needle assembly 3600 may include firing tube 3603. Firing tube 3603 may include lumen 3605. A firing apparatus (which may include firing tube 3603 and peg 3616, but otherwise is not shown) may act on firing post 3616 to eject needle 3601 from tube 3603 and into myocardium Hm (not shown). The insertion of needle 3601 may be the establishment of an access opening such as Ho (shown in FIG. 1).
  • Distal end 3618 of firing tube 3603 may be placed adjacent or within an intercostal region. Firing tube may be angled toward heart Hm. Distal end 3618 of firing tube 3603 may be placed on heart Hm. Distal end 3618 of firing tube 3603 may be placed on the skin.
  • The firing apparatus may be used to insert needle 3601 into myocardium Hm is a surgical setting in which a surface of heart (H) is exposed, in a percutaneous setting in which access to heart H is provided by a small incision or in a strictly percutaneous setting in which needle 3601 is ejected from tube 3603 through the skin and into myocardium Hm.
  • Needle 3601 may include elongated member 3602. Elongated member 3602 may be cannulated. Elongated member 3602 may be uncannulated. Elongated member may not include a delivery lumen.
  • Elongated member 3602 may include outer surface 3604. Outer surface 3604 may resist closure of access opening Ho (shown in FIG. 1) in heart wall Hw (shown in FIG. 1). The pressure of heart wall Hw on outer surface 3604 may be sufficient to prevent the leakage of blood Hb from interior Hi of chamber Hc between outer surface 3604 and heart wall Hw to exterior Hext of heart H. The pressure may be sufficient to do so even in the absence of a seal at the contact between outer surface 3604 and heart wall Hw.
  • Needle 3601 may include one or more electrically conductive members such as 3606. One or more of electrically conductive members 3606 may be supported by elongated member 3602. One or more of electrically conductive members 3606 may be used to provide electrical pulses to heart wall Hw to change the contraction frequency. One or more of electrically conductive members 3606 may be placed in direct contact with heart wall Hw to provide the electrical pulses. The energy may be supplied via a cable such as 3608 from a source such as 110 (shown in FIG. 1). The energy may be supplied wirelessly from source 110. An electrically conductive member may be placed on the skin or on the heart surface to complement current supplied by electrically conductive member 3606.
  • Electrically insulating members 3610 may electrically insulate electrically conducting members 3606 from elongated member 3602. When elongated member 3602 is an electrical insulator, electrically insulating members 3610 may not be included.
  • Cable 3608 may be wound about firing post 3612. A driving force may be delivered to receptacle 3614 inside post 3612. The driving force may be supplied by peg 3616. Peg 3616 may be driven by any suitable mechanism. For example, peg 3616 may be driven by a spring or compressed gas or by hand. Peg 3616 may drive needle 3612 longitudinally and allow needle 3612 to disengage from peg 3616 and penetrate myocardium Hm. Needle 3601 may be driven directly by the spring or compressed gas or by the hand.
  • When needle 3601 is driven distally, cable 3608 may unravel from drive post 3612. A practitioner may pull on cable 3608 to evaluate whether needle 3612 has become lodged in myocardium Hm.
  • Needle assembly 3600 may include more than one firing tube. Each firing tube may include one needle. When each needle includes one electrically conductive member, the two or more needles may provide current to different locations in the heart. The different locations may be proximate each other, for example, within 1-5 needle diameters of each other. The different locations may be apart from each other, for example, within 6-10, 10-20 or more needle diameters from each other.
  • One or more additional electrically conductive members may have a distal end that is placed in electrical communication with epidermal tissue on the body in which the heart is disposed. The one or more additional electrically conductive members may have a proximal end that is in electrical communication with control panel 3612.
  • FIG. 37 shows, along lines 37-37 (shown in FIG. 36), a cross-section of needle 3601. Electrically conductive members 3606 and electrically insulating members 3610 may be flush with outer surface 3604 of elongated member 3602.
  • FIG. 38 shows, in a view similar to that along lines 36-36 (shown in FIG. 36), a cross-section of instrument 3800, which may have one or more features in common with needle 3601. Instrument 3800 may include elongated member 3802. Elongated member 3802 may include outer surface 3804. Instrument 3800 may include electrically conductive members 3806 and electrically insulating members 3810. Electrically conductive members 3806 may extend radially away from outer surface 3804. Electrically insulating members 3810 may be flush with outer surface 3804. When elongated member 3802 is an electrical insulator, electrically insulating members 3810 may not be included.
  • Thus, apparatus and methods for delivering an instrument through an access opening in an exterior heart wall have been provided. Persons skilled in the art will appreciate that the present invention can be practiced by other than the described embodiments, which are presented for purposes of illustration rather than of limitation.
  • The present invention is limited only by the claims that follow.

Claims (20)

What is claimed is:
1. Apparatus for delivering an instrument through an access opening in an exterior heart wall, the heart wall having a contraction frequency, the apparatus comprising:
an elongated member having:
a delivery lumen that is configured to traverse the heart wall, the lumen having a proximal opening for receiving the instrument and a distal opening for deploying the instrument; and
an outer surface that is configured to maintain the access opening; and
an electrically conductive member that is supported by the elongated member and is configured to deliver to the heart wall a current that modifies the frequency.
2. The apparatus of claim 1 wherein the electrically conductive member is configured to provide to the heart wall a series of pulses.
3. The apparatus of claim 1 wherein the electrically conductive member is configured to be in direct contact with the heart wall.
4. The apparatus of claim 1 wherein the electrically conductive member is configured to slide through the access opening while delivering the current.
5. The apparatus of claim 1 further comprising an antenna that is supported by the elongated member and is configured to sense a native cardiac electric field in a chamber interior the heart wall and communicate a corresponding native cardiac signal to a receiver exterior the heart wall.
6. The apparatus of claim 1 further comprising a pressure sensor that is configured to sense a pressure in a chamber interior the heart wall and transmit a corresponding pressure signal to a receiver exterior the heart wall.
7. The apparatus of claim 1 further comprising a chemical sensor that is configured to sense a chemical species at a myocardial tissue surface that is exposed in a heart wall access opening and transmit a corresponding chemical signal to a receiver exterior the heart wall.
8. The apparatus of claim 17 wherein the electrically conductive member is configured to be released from the elongated member and inserted in the heart wall.
9. The apparatus of claim 1 wherein:
when a portion of the elongated member is in a contracted state, a portion of the electrically conductive member is disposed at a first radial distance from a longitudinal central axis of the delivery lumen; and
when the portion of the elongated member is in an expanded state, the portion of the electrically conductive member is disposed at a second radial distance from the axis, the second radial distance being greater than the first radial distance.
10. The apparatus of claim 9 wherein:
the portion of the electrically conductive member is a first portion; and
a second portion of the electrically conductive member, disposed longitudinally away from the first portion, is disposed at the first radial distance from the axis.
11. Apparatus for plugging an access opening in a heart wall of a heart, the apparatus comprising:
a body that includes:
a distal end that is configured to be disposed interior the heart and contact endocardial tissue adjacent the access opening; and
a proximal end that is configured to be disposed exterior the heart and contact heart tissue adjacent the access opening; and
an electrode that is supported by the body and is configured to discharge electrical energy into the heart wall to change a frequency of contraction of the heart.
12. The apparatus of claim 11 further comprising a stem that extends between the distal end and the proximal end.
13. The apparatus of claim 11 wherein:
the stem has a first diameter;
the distal end has a second diameter that is greater than the first diameter; and
the proximal end has a third diameter that is greater than the first diameter.
14. The apparatus of claim 11 wherein the electrode discharges from the distal end.
15. The apparatus of claim 11 wherein the electrode discharges from the proximal end.
16. The apparatus of claim 11 further comprising, when the electrode is a first electrode, a second electrode that is configured to discharge electrical energy into the heart wall to change the frequency of contraction of the heart.
17. The apparatus of claim 11 further comprising a sensor for sensing a native cardiac electric field.
18. A method for delivering an instrument to the interior of a heart, the method comprising:
inserting an elongated member through an access opening in the heart;
transferring electrical energy from the elongated member to the heart to change a frequency of contractions of the heart; and
delivering an instrument through the elongated member.
19. Apparatus for pacing a heart, the apparatus comprising:
a sharp end that is configured to pierce tissue;
a base opposite the sharp end, the base being configured to receive an impulse to drive the sharp end into the tissue;
an elongated member bearing an electrode, the elongated member extending from the sharp end to the base; and
an electrically conducting lead that is connected to the electrode and is configured to receive current for delivery to the heart through the electrode when the electrode is embedded in the heart.
20. The apparatus of claim 19 further comprising, when the electrode is a first electrode and the electrically conducting lead is a first electrically conducting lead:
a second electrode that is borne by the elongated member; and
a second electrically conducting lead that is connected to the electrode and is configured to receive current for delivery to the heart through the second electrode when the second electrode is embedded in the heart.
US13/737,151 2012-01-09 2013-01-09 Electrophysiological endocardiology tool Abandoned US20130178908A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/737,151 US20130178908A1 (en) 2012-01-09 2013-01-09 Electrophysiological endocardiology tool

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261631639P 2012-01-09 2012-01-09
US13/737,151 US20130178908A1 (en) 2012-01-09 2013-01-09 Electrophysiological endocardiology tool

Publications (1)

Publication Number Publication Date
US20130178908A1 true US20130178908A1 (en) 2013-07-11

Family

ID=47602671

Family Applications (1)

Application Number Title Priority Date Filing Date
US13/737,151 Abandoned US20130178908A1 (en) 2012-01-09 2013-01-09 Electrophysiological endocardiology tool

Country Status (4)

Country Link
US (1) US20130178908A1 (en)
EP (1) EP2802379A2 (en)
CA (1) CA2897231A1 (en)
WO (1) WO2013104079A2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140371841A1 (en) * 2013-06-13 2014-12-18 Medtronic Vascular Galway Delivery System with Pacing Element
WO2016066180A1 (en) * 2014-10-30 2016-05-06 Osypka Stiftung Peter Transmyocardial insertion unit and its use
US20170266434A1 (en) * 2016-03-18 2017-09-21 Vascular Solutions, Inc. Pacing guidewire
US20180070934A1 (en) * 2012-12-10 2018-03-15 Peter Osypka Stiftung Implantable sealing device
WO2018065523A1 (en) * 2016-10-07 2018-04-12 Electroducer Assembly for replacing a heart valve or a coronary angioplasty assembly
FR3057153A1 (en) * 2016-10-07 2018-04-13 Benjamin FAURIE ELECTRICAL CONDUCTIVE SLEEVE FOR A DELIVERY OR INTRODUCING CATHETER OF A REPLACEMENT ASSEMBLY OF A CARDIAC VALVE OR A CORONARY ANGIOPLASTY ASSEMBLY
FR3057154A1 (en) * 2016-10-07 2018-04-13 Benjamin FAURIE TRANSCUTANEOUS ELECTRODE FOR A CARDIAC VALVE REPLACEMENT ASSEMBLY OR CORONARY ANGIOPLASTY ASSEMBLY COMPRISING A DELIVERY CATHETER OR INTRODUCER
WO2018085545A1 (en) * 2016-11-03 2018-05-11 St. Jude Medical, Cardiology Division, Inc. Leadless pacemaker with collapsible anchoring device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3680544A (en) * 1970-09-09 1972-08-01 James P Shinnick Transthoracic cannula-type device for cardiopulmonary resuscitation
US20020032468A1 (en) * 1996-04-30 2002-03-14 Hill Michael R.S. Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure
US20050080470A1 (en) * 2003-10-09 2005-04-14 Randy Westlund Intramyocardial lead implantation system and method
US20060135877A1 (en) * 2004-12-17 2006-06-22 Medtronic, Inc. System and method for monitoring or treating nervous system disorders
US7840281B2 (en) * 2006-07-21 2010-11-23 Boston Scientific Scimed, Inc. Delivery of cardiac stimulation devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015791A1 (en) * 1992-02-12 1993-08-19 Dimed, Incorporated System for access to pericardial space
US7052493B2 (en) * 1996-10-22 2006-05-30 Epicor Medical, Inc. Methods and devices for ablation
US20010044619A1 (en) * 1998-04-08 2001-11-22 Peter A. Altman Cardiac drug delivery system and method for use
US8303511B2 (en) * 2002-09-26 2012-11-06 Pacesetter, Inc. Implantable pressure transducer system optimized for reduced thrombosis effect

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3680544A (en) * 1970-09-09 1972-08-01 James P Shinnick Transthoracic cannula-type device for cardiopulmonary resuscitation
US20020032468A1 (en) * 1996-04-30 2002-03-14 Hill Michael R.S. Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure
US20050080470A1 (en) * 2003-10-09 2005-04-14 Randy Westlund Intramyocardial lead implantation system and method
US20060135877A1 (en) * 2004-12-17 2006-06-22 Medtronic, Inc. System and method for monitoring or treating nervous system disorders
US7840281B2 (en) * 2006-07-21 2010-11-23 Boston Scientific Scimed, Inc. Delivery of cardiac stimulation devices

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180070934A1 (en) * 2012-12-10 2018-03-15 Peter Osypka Stiftung Implantable sealing device
US10758217B2 (en) * 2012-12-10 2020-09-01 Peter Osypka Stiftung Implantable sealing device
US10426615B2 (en) 2013-06-13 2019-10-01 Medtronic Vascular Galway Delivery system with pacing element
US9326854B2 (en) * 2013-06-13 2016-05-03 Medtronic Vascular Galway Delivery system with pacing element
US11241311B2 (en) 2013-06-13 2022-02-08 Medtronic Vascular Galway Delivery system with pacing element
US20140371841A1 (en) * 2013-06-13 2014-12-18 Medtronic Vascular Galway Delivery System with Pacing Element
WO2016066180A1 (en) * 2014-10-30 2016-05-06 Osypka Stiftung Peter Transmyocardial insertion unit and its use
US10456168B2 (en) 2014-10-30 2019-10-29 Peter Osypka Stiftung Transmyocardial insertion unit and its use
US10758725B2 (en) 2016-03-18 2020-09-01 Cardiac Interventions And Aviation Llc Pacing guidewire
US10173052B2 (en) * 2016-03-18 2019-01-08 Teleflex Innovations S.À.R.L. Pacing guidewire
US10881851B2 (en) 2016-03-18 2021-01-05 Cardiac Interventions And Aviation Llc Pacing guidewire
US20170266434A1 (en) * 2016-03-18 2017-09-21 Vascular Solutions, Inc. Pacing guidewire
US11420046B2 (en) 2016-03-18 2022-08-23 Cardiac Interventions And Aviation Llc Pacing guidewire
FR3057154A1 (en) * 2016-10-07 2018-04-13 Benjamin FAURIE TRANSCUTANEOUS ELECTRODE FOR A CARDIAC VALVE REPLACEMENT ASSEMBLY OR CORONARY ANGIOPLASTY ASSEMBLY COMPRISING A DELIVERY CATHETER OR INTRODUCER
FR3057153A1 (en) * 2016-10-07 2018-04-13 Benjamin FAURIE ELECTRICAL CONDUCTIVE SLEEVE FOR A DELIVERY OR INTRODUCING CATHETER OF A REPLACEMENT ASSEMBLY OF A CARDIAC VALVE OR A CORONARY ANGIOPLASTY ASSEMBLY
WO2018065523A1 (en) * 2016-10-07 2018-04-12 Electroducer Assembly for replacing a heart valve or a coronary angioplasty assembly
US11382745B2 (en) 2016-10-07 2022-07-12 Electroducer Assembly for replacing a heart valve or a coronary angioplasty assembly
WO2018085545A1 (en) * 2016-11-03 2018-05-11 St. Jude Medical, Cardiology Division, Inc. Leadless pacemaker with collapsible anchoring device
US11433247B2 (en) 2016-11-03 2022-09-06 St. Jude Medical, Cardiology Division, Inc. Leadless pacemaker with collapsible anchoring device

Also Published As

Publication number Publication date
EP2802379A2 (en) 2014-11-19
WO2013104079A3 (en) 2013-09-06
CA2897231A1 (en) 2013-07-18
WO2013104079A2 (en) 2013-07-18

Similar Documents

Publication Publication Date Title
US20130178908A1 (en) Electrophysiological endocardiology tool
EP3672532B1 (en) Implantable cardiac pacing system
US20210379364A1 (en) Substernal placement of a pacing and/or defibrillating electrode
US20220117736A1 (en) Annuloplasty procedures, related devices and methods
US10537731B2 (en) Transvenous mediastinum access for the placement of cardiac pacing and defibrillation electrodes
US10980570B2 (en) Implantation of an active medical device using the internal thoracic vasculature
US11039923B2 (en) Annuloplasty procedures, related devices and methods
US20210186696A1 (en) Assembly for replacing a heart valve or coronary angioplasty assembly including a delivery catheter with or without introducer
US9597514B2 (en) Epicardial heart rhythm management devices, systems and methods
US10786679B2 (en) Lead with integrated electrodes
EP3380188B1 (en) Pacing guidewire
US10758724B2 (en) Implantable medical device delivery system with integrated sensor
US20180133463A1 (en) Electrode for sensing, pacing, and defibrillation deployable in the mediastinal space
CN104203341A (en) Tethered implantable medical device deployment
US20060241732A1 (en) Catheter system for implanting an intravascular medical device
US20090318989A1 (en) Pacing catheter with stent electrode
US20090318994A1 (en) Transvascular balloon catheter with pacing electrodes on shaft
US11007059B2 (en) Annuloplasty procedures, related devices and methods
US10716552B2 (en) Implantable sealing device
CN114901212A (en) Valvuloplasty and pacing procedures, related devices and methods
US20150282789A1 (en) Closure Device

Legal Events

Date Code Title Description
AS Assignment

Owner name: ENDOHEART AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HUBER, CHRISTOPH HANS;REEL/FRAME:029668/0692

Effective date: 20130107

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION